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Abstract 
 
The Thesis aimed to provide evidence on the incorporation of Lactobacillus spp. 
into different dosage forms keeping their viability and antibacterial activity. In order to 
achieve this aim, the survival of probiotic microorganisms in freeze-dried powders, 
tablets, pellets, calcium alginate beads and films has been investigated. Two strategies 
were used: a) direct incorporation of bacterial suspensions into pellets, sodium alginate 
beads and films and b) incorporation of freeze-dried bacteria into tabletting excipients to 
produce tablets. 
 The vegetative forms of Lactobacillus plantarum, Lactobacillus rhamnosus strain 
GG, Lactobacillus lactis and Lactobacillus bulgaricus and a spore form of Bacillus 
subtilis were considered as model bacterial strains. The different bacteria chosen have 
shown different viabilities to formulation and processing with decreasing viability as 
follows: B. subtilis, L. plantarum, L. rhamnosus GG and L. bulgaricus. 
The process of drying was critical for obtaining a high survival rate. Freeze drying 
allowed high viability (≤1 log unit decrease) contrary to air drying observed during the 
process of extrusion-spheronisation and subsequent fluid bed drying. Nutrients and 
cryoprotectants (skim milk, glycerol, mannose, calcium alginate) should be present at 
early stages of processing, before de-hydration, to promote the stabilization of bacteria. 
Pressure, whether applied during extrusion or compaction, reduced bacterial viable 
counts. Tabletting of freeze-dried bacteria alone or together with inulin had a less 
deleterious effect on bacterial viability (1-2 log unit decrease during compaction 
followed by 1-2 log unit during storage) compared to pelletisation (in some cases 3 log 
units during processing, reaching minimum of detection in 1 to 4 months). However, 
tabletting of freeze-dried bacteria together with microcrystalline cellulose had a 
detrimental effect on bacterial viability comparable to pelletisation. Coating of either 
tablets or pellets was considered less deleterious compared to tabletting and 
pelletisation. Coating caused an initial decrease of viability (<1 log unit) but did not 
affect the survival rates further during storage. The highest survival rates of probiotic 
bacteria were obtained by the technique of immobilization into calcium alginate beads 
and films: ≤1 log unit decrease during freeze-drying of beads and films and <1 log unit 
during storage. 
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The antibacterial activity of lactobacilli against multi-resistant clinical isolates (upon 
their preservation in calcium alginate beads and films) has been observed. Lactobacilli, 
particularly whole cultures, at high cell concentrations (108 cfu/ml) were inhibitory 
active. The antibacterial activity of the lactobacilli remained stable during processing 
and storage provided the viability was preserved (L. plantarum, LGG and L. lactis). 
Immobilized lactobacilli caused a 5 to 6 log unit reduction of a VIM-2-metalo-β-
lactamase producing Pseudomonas aeruginosa in rat burns: from 107-108 to 102 P. 
aeruginosa / g of skin in 8 hours. 
It has been demonstrated the successful production of various dosage forms for the 
delivery of viable lactobacilli with antibacterial activity against multi-resistant bacteria. 
The developed dosage forms could contribute to the use of lactobacilli as an alternative 
in topical prevention of burn wound infections. 
 
 
 
Keywords: antibacterial activity, burn wound, calcium alginate immobilisation, 
Lactobacillus spp., mini-tablets, multi-resistant clinical isolates, pellets, viability. 
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Resumo 
O objectivo desta tese é demonstrar a incorporação de Lactobacillus spp. em 
diferentes formas farmacêuticas mantendo a sua viabilidade e actividade antibacteriana. 
Para obter este objectivo, foi investigada a sobrevivência dos microrganismos 
probióticos em pós liofilizados, comprimidos, pellets, beads e filmes de alginato de 
cálcio. Foram usadas duas estratégias: a) incorporação directa de suspensões bacterianas 
para produzir pellets, beads e filmes de alginato de cálcio e b) incorporação de bactérias 
liofilizadas em excipientes para produzir comprimidos. 
As formas vegetativas Lactobacillus plantarum, Lactobacillus rhamnosus estirpe 
GG, Lactobacillus lactis e Lactobacillus bulgaricus e Bacillus subtilis em forma de 
esporos foram considerados como modelo de estirpe bacteriana. As diferentes bactérias 
seleccionadas demonstraram diferentes viabilidades à formulação e produção, com 
viabilidade decrescente na seguinte sequência: B. subtilis, L. plantarum, L. rhamnosus 
GG e L. bulgaricus. 
O processo de secagem foi crítico para a obtenção de altas taxas de sobrevivência. 
Liofilização permitiu alta viabilidade (≤1 unidade logarítmica de decréscimo) 
contrariamente à secagem ao ar observada durante o processo de extrusão e 
esferonização e subsequente secagem por leito fluido. Nutrientes e crioprotectores (skim 
milk, glicerol, manose, alginato de cálcio) devem estar presentes nas fases iniciais do 
processo, antes da desidratação, para promover a estabilização das bactérias. A pressão, 
aplicada durante a extrusão ou compactação, reduziu a viabilidade. A produção de 
comprimidos de bactérias liofilizadas com ou sem inulina teve um menor efeito 
deletério na viabilidade (1 a 2 unidades logarítmicas de decréscimo durante a 
compactação seguida por 1 a 2 unidades logarítmicas de decréscimo durante 
armazenamento) quando comparada com a peletização (3 unidades logarítmicas de 
decréscimo nalguns casos, atingindo a detecção mínima ao fim de 1 a 4 meses). No 
entanto, a produção de comprimidos de bactérias liofilizadas em conjunto com celulose 
microcristalina teve um efeito deletério na viabilidade comparável ao da peletização. O 
revestimento de comprimidos ou pellets foi considerado menos deletério do que a 
produção de comprimidos ou peletização. O revestimento causou um decréscimo inicial 
de viabilidade (<1 unidade logarítmica) mas não afectou as taxes de sobrevivência 
durante o armazenamento. As mais altas taxas de sobrevivência de bactérias probióticas 
foram obtidas com a técnica de imobilização em beads e filmes de alginato de cálcio: ≤1 
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unidade logarítmica de decréscimo durante liofilização de beads e filmes e <1 unidade 
logarítmica durante armazenamento. 
Foi observada a actividade antibacteriana de lactobacilli contra isolados clínicos 
multi-resistentes (após a sua preservação em beads e filmes de alginato de cálcio). 
Observou-se que lactobacilli, particularmente as culturas inteiras, em altas 
concentrações celulares (108 cfu/ml) provocaram inibição. A actividade antibacteriana 
dos lactobacilli permaneceu estável durante o processamento e armazenamento desde 
que a viabilidade fosse preservada (L. plantarum, LGG e L. lactis). Lactobacilli 
imobilizados causaram um decréscimo de 5 a 6 unidades logarítmicas de VIM-2-
metalo-β-lactamase produzindo Pseudomonas aeruginosa em queimaduras de ratos: de 
107-108 a 102 P. aeruginosa / g de pele em 8 horas. 
Foi demonstrada a produção com sucesso de várias formas farmacêuticas para a 
administração de lactobacilli viáveis com actividade inibitória contra bactérias multi-
resistentes. As formas de dosagem desenvolvidas podem contribuir para o uso tópico de 
lactobacilli como alternativa à prevenção de infecções em queimaduras. 
 
 
Palavras chave: actividade antibacteriana, imobilização em alginato de cálcio, isolados 
clínicos multi-resistentes, Lactobacillus spp., mini-comprimidos, pellets, queimadura, 
viabilidade. 
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CHAPTER 1 
 
LACTOBACILLI AND OTHER PROBIOTIC BACTERIA 
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1.1 General considerations of lactobacilli and other probiotic bacteria 
 A beneficial association of microorganisms with the human host was suggested by 
Metchnikoff in 1907. He considered the longevity of the Bulgarian people to be related 
to the high intake of fermented milk products containing Bacillus bulgaricus. About 100 
years later there has been a growing interest in beneficial bacteria and their effects. The 
term probiotic has been introduced and defined as live microorganisms that, when 
administered in adequate amounts confer a health benefit on the host (FAO/WHO, 
2002). In order to qualify as probiotic, microorganisms should fulfil most, if not all, of 
the criteria listed in Table 1.1. The established probiotics that meet these criteria are 
generally lactic acid bacteria (LAB), most commonly Lactobacillus and 
Bifidobacterium species, but Lactococcus, Streptococcus and Enterococcus species, as 
well as some non-pathogenic strains of Escherichia coli and certain yeast strains also 
qualify. There has been increasing evidence that probiotic strains can exhibit the same 
activities as commensal bacteria, including immunomodulation and protection of the 
host from pathogens by competitive exclusion (Borchers et al., 2009). 
 
Table 1.1 Criteria for the use of probiotics in humans. 
Identified at the genus, species and strain level
 Strain should be deposited in an international culture collection;
Safe for food and clinical use
 Non pathogenic; Non degrading the intestinal mucosa; Not carrying transferable antibiotic resistance 
genes; Not conjugating bile acids; Susceptible to antibiotics
Able to survive intestinal transit
 Acid and bile tolerant
Able to adhere to mucosal surfaces
Able to colonize the human intestine or vagina (at least temporarily)
Producing antimicrobial substances
Able to antagonize pathogenic bacteria
Possessing clinically documented and validated health effects
Stable during processing
 
(adapted after Borchers et al., 2009) 
 
The present work will be focused on Lactobacillus species as main representatives 
of probiotic bacteria. Their application as bacteriotherapy and methods for stabilization 
into delivery systems will be reviewed in this chapter. 
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1.1.1 Genus Lactobacillus  
 The genus Lactobacillus is the largest group among the Lactobacillaceae, and 
contains over 100 species (Felis and Dellaglio, 2007). Lactobacilli are Gram-positive, 
microaerophilic, non-spore forming rod-shaped bacteria, for which motility is 
uncommon. However, when present, motility is performed by peritrichous flagella. 
Cells, varying from long and slender, sometimes bent to short, often coryneform 
coccobacilli, often form chains (Figure 1.1).  
  
 
Figure 1.1 Phase contrast (A-E) and electronic micrographs (F) showing different cell morphology of 
lactobacilli (A, L. gasseri; B, L. agilis; C, L. curvatus; D, L. minor; E, L. fermentum; F, involution form of 
lactobacilli in a thin section of kefir grain) (after Kandler and Weiss, 1986). 
 
Growth temperature ranges from 2 to 53ºC with optimum generally between 30 and 
40ºC. Optimal pH usually ranges from 5.5 to 6.2. Growth generally occurs at 5.0 or less 
and is often reduced at neutral or initially alkaline reactions. Lactobacilli are found in 
dairy products, grain products, meat and fish products, water, sewage, beer, wine, fruits 
and fruit juices, pickled vegetables, sauerkraut, silage, sour dough, and mash. Species 
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mostly isolated from fermented vegetable feed and food and beverages are: L. 
plantarum, L. brevis, L. coryniformis, L. casei, L. curvatus, L. sakei, L. fermentum. The 
most common naturally occurring species in ripening raw sausages are L. plantarum, L. 
brevis, L. farciminis, L. alimentarius, L. sakei and L. curvatus. Several species are 
typical of specific products. Thus, L. delbrueckii subsp. delbrueckii exhibiting a very 
narrow range of fermented carbohydrates is the characteristic organism found in potato 
and grain mashes fermented at 40-55ºC. Very specifically adapted lactobacilli for the 
production of sour milks are L. delbrueckii subsp. bulgaricus and L. kefir. Lactobacilli 
are a part of the normal flora in the mouth, intestinal tract and vagina of humans and 
many homothermic animals. L. salivarius is the most typical species of the mouth flora, 
although it is also found in the intestinal tract. The most prominent species, probably 
indigenous to the intestine is L. acidophilus (Kandler and Weiss, 1986). Lactobacilli are 
generally considered non-pathogenic. The genome G+C (guanine + cytosine) content 
ranges from 32 to 53 mol%. The type species is Lactobacillus delbrueckii (Kandler and 
Weiss, 1986; Felis and Dellaglio, 2007). The phylogenetic grouping of lactobacilli 
species is represented in Table 1.2. 
 
Table 1.2 Phylogenetic grouping. Groups are ordered according to the number of species included in 
each group. 
Groups Species
L. delbrueckii group L. acetotolerans, L. acidophilus, L. amylolyticus, L. amylophilus, L. amylotrophicus, L. 
amylovorus, L. crispatus, L. delbrueckii,L. fornicalis, L. gallinarum, L. gasseri, L. hamsteri, L. 
helveticus, L. iners, L. intestinalis, L. jensenii, L. johnsonii, L. kalixensis, L. kefiranofaciens, L. 
kitasatonis, L. psittaci, L. sobrius, L. ultunensis
L. salivarius group L. acidipiscis, L. agilis, L. algidus*, L. animalis, L. apodemi, L. aviarius, L. equi, L. mali, L. 
murinus, L. nageli, L. ruminis, L.saerimneri, L. salivarius, L. satsumensis, L. vini
L. reuteri group L. antri, L. coleohominis, L. fermentum, L. frumenti, L. gastricus, L. ingluviei, L.mucosae, L. 
oris, L. panis, L. pontis, L.reuteri, L. secaliphilus, L. vaginalis
L. buchneri group L. buchneri, L. diolivorans, L. farraginis, L. hilgardii, L. kefiri, L. parabuchneri, L. parafarraginis, 
L. parakefiri associated with L. acidifarinae, L. namurensis, L. spicheri, L. acidifarinae, L. 
namurensis, L. spicheri and L. zymae (which form a robust group)
L. alimentarius-L. farciminis group L. alimentarius, L. farciminis, L. kimchii, L. mindensis, L. nantensis, L. paralimentarius, L. 
tucceti, L. versmoldensis
L. casei group L. casei, L. paracasei, L. rhamnosus, L. zeae
L. sakei group L. curvatus, L. fuchuensis, L. graminis, L. sakei
L. fructivorans group L. fructivorans, L. homohiochii, L. lindneri, L. sanfranciscensis
L. coryniformis group L. bifermentans, L. coryniformis, L. rennini, not robustly associated with L. composti
L. plantarum group L. plantarum, L. paraplantarum, L. pentosus
L. perolens group L. perolens, L. harbinensis, L. paracollinoides
L. brevis group L. brevis, L. hammesii, L. parabrevis
Pediococcus dextrinicus group P. dextrinicus, L. concavus, L. oligofermentans (the latter sometimes poorly supported)
Pediococcus 2 clusters, not associated: the first comprises P. cellicola, P. damnosus P. parvulus, P. 
inopinatus, while the second includes P. acidilactici, P. claussenii, P. pentosaceus and P. 
stilesii
Couples L. rossiae-L. siliginis L. vaccinostercus-L. suebicus L. manihotivorans-L. collinoides
Single species L. kunkeei, L. malefermentans, L. pantheris, L. sharpeae, Paralactobacillus selangorensis
 
(adapted from Felis and Dellaglio, 2007) 
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1.1.2 Bacteriotherapy 
The competition among microorganisms and interaction with mammalian host has 
been evolving for millions of years. The fact that we have survived is in no small part 
owing to the ability of commensal bacteria to protect the host from microbial induced 
diseases (Reid et al., 2001). Starting from the first hours after the delivery the 
interaction of the host with microorganisms begins. This interaction leads to 
colonisation of host epithelial surfaces. Of these surfaces mucosa represents in humans 
about 300 m2 while skin covers approximately 2 m2 surface of the human body. Human 
individuals are consequently complex ecosystems formed by 1013 mammalian cells and 
by commensal microflora (approximately 1014 microbes) (Tlaskalová-Hogenová et al., 
2004). Commensal microflora is an integral part of a complex of natural mechanisms on 
mucosal surfaces and skin that at an optimal composition prevents attachment and 
colonisation of pathogenic microorganisms and their invasion into epithelial cells and 
circulation. Some of these pathogens are already part of the indigenous microflora 
(staphylococci, streptococci, Corynebacterium; Gram-negative cocci), whereas others, 
such as Salmonella, are truly foreign invaders. Beside the direct interaction with 
pathogenic bacteria commensal microflora plays an important role in anti-infectious 
resistance by its influence on immune system. Commensal microflora stimulates the 
development of both local and systemic immunity and later on, it evokes, on the 
contrary, regulatory (inhibitory) mechanisms (oral, mucosal tolerance) intended to keep 
both mucosal and systemic immunity in balance (Tlaskalová-Hogenová et al., 2004). 
The significant role of the host microflora for resistance to disease has been well 
illustrated by Collins and Carter in 1978. The introduction of less than 10 viable 
Salmonella enteridis into the germfree mice intestinal tract represented a 100% lethal 
dose, whereas 1 x 109 bacteria were required to kill animals with complete intestinal 
microflora. 
The idea to use harmless commensal or probiotic bacteria to replace pathogenic 
bacteria at skin and mucosa has emerged from microbial ecology and competitive 
exclusion studies. Bacterial interference is an increasingly attractive approach for 
prevention and therapy (Reid et al., 2001; Huovinen, 2001; Peral et al., 2009; Huang et 
al., 2009; Skovbjerg et al., 2009). In this respect lactobacilli, as part of the commensal 
microbial flora of the intestinal tract of humans and mammals and main representatives 
of probiotic bacteria, can be useful candidates (Peral et al., 2009; Huang et al., 2009). 
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Lactobacilli are considered as GRAS (Generally Recognized As Safe) organisms with a 
very long record of safe oral consumption. They are shown to modulate host immunity 
and neutralize pathogens. Furthermore, lactobacilli confer the advantage that they can 
be engineered to deliver therapeutics. 
 
1.1.2.1 Probiotic bacteria and immunity  
Numerous studies have demonstrated that probiotic bacteria enhance non-specific 
and specific host immune responses to microbial pathogens. The oral pre-treatment with 
a lyzozyme lysate from L. bulgaricus (Deodan) activated the phagocytic and secretory 
functions of mononuclear cells and decreased the mortality in mice infected 
intraperitoneally with Klebsiella pneumoniae and Listeria monocytogenes (30% 
mortality of Deodan treated mice vs 70% in control group infected with K. pneumoniae 
and 80% with L. monocytogenes) (Popova et al., 1993). The consumption of L. 
acidophilus (Schiffrin et al., 1995) and L. johnsonii (Donnet-Hughes et al., 1999) 
increased leukocyte phagocytic activity in healthy adults. Phagocytosis is responsible 
for early activation of the inflammatory response before antibody production. 
Phagocytes release toxic agents, e.g. reactive oxygen intermediates and lytic enzymes, 
in various inflammatory reactions. Phagocytic activity results in further recruitment of 
immunocompetent cells and the generation of inflammatory response. Gill et al., 2000, 
observed that supplementation with L. rhamnosus, L. acidophilus and Bifidobacterium 
lactis resulted in increase in phagocytic activity of peripheral blood leucocytes and 
peritoneal macrophages, NK (natural killer)-cell activity, IFN-γ (interferon-γ) 
production and antibody responses to orally (cholera toxin) and systemically (tetanus 
vaccine) administered antigens in healthy mice. 
 It has been shown that orally ingested probiotic bacteria can activate immune 
responses at distant mucosal sites. This phenomenon is based on one impressive feature 
of the immune system, which is the mobility of its cells. Following antigen stimulation 
in Payer’s patches (PP) and its presentation to B and T cells, the antigen induced B and 
T cells (CD4+ and CD8+) are able to migrate via efferent lymphatics and through the 
mesenteric node; they reach the systemic circulation through the thoracic duct and 
repopulate not only the lamina propria of the intestine but other distant mucosal sites 
such as respiratory, urogenital, exocrine glands such as lachrymal, salivary, mammary 
and prostatic glands (Brandtzaeg and Pabst, 2004). This phenomenon has been called 
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the Common Mucosal System. It can explain the observed by Gluck and Gebbers, 2003, 
reduction (19%) in the occurrence of nasal potentially pathogenic bacteria 
(Staphylococcus aureus, Streptococcus pneumoniae, β-haemolytic streptococci and 
Haemophilus influenzae) after ingestion of a probiotic drink containing Lactobacillus 
rhamnosus strain GG (LGG), Streptococcus thermophilus, L. acidophilus and 
Bifidobacterium. 
Epithelial intestinal cells are another important component of the mucosal immune 
system. The epithelial cells communicate with other mucosal cells via a spectrum of 
mediators that act on the intestinal epithelial cells as well as on the intraepithelial 
lymphocytes, lymphoid cells, and mononuclear phagocytes. The cascade of mediators is 
regulated to induce or to down-regulate appropriate host immune and inflammatory 
responses at mucosal surfaces (Perdigon et al., 2001). Whatever the route of the 
secretory immune response induction, the result is that by oral stimulation, distant 
mucosal sites can be repopulated with IgA producing cells to protect these surfaces. 
Oral administration of L. casei, L. bulgaricus, L. plantarum, L. rhamnosus, Lactococcus 
lactis and S. thermophilus induced an increase in the sIgA cells in the bronchus of mice. 
The increase of the CD4+ cells induced by L. plantarum, L. rhamnosus and S. 
thermophilus suggested interaction at the Payer’s patches. No specific antibodies were 
determined against L. lactis and L. bulgaricus.  Thus, these bacteria have been bound to 
epithelial cells that activated B lymphocytes without processing and presenting their 
epitops (Perdigon et al., 1999). 
In spite of the ability of the common mucosal system to induce a good local mucosal 
response, local stimulation is also required. In 2005 de Moreno de LeBlanc et al. 
demonstrated immunoregulatory capacity of oral administered milk fermented by L. 
helveticus on the immune response in mammary glands in presence of a local pathology 
(breast tumour). Mice fed with L. helveticus fermented milk and injected with breast 
tumour cells increased IgA and CD4 positive cells, tumour control increased CD8+ 
cells, while mice from fermented milk control group (without tumour cell injection) did 
not show changes in immune cell or cytokine positive cell numbers. IL (interleukin)-10 
increase and IL-6 decrease were more pronounced in mice fed with fermented milk than 
in the other groups. 
The release of cytokines by the immune cells plays an important role in triggering 
the immune response. Cytokine interventions could be used to stimulate or suppress 
immunity. Probiotic bacteria have been reported to modulate the immunological 
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functions of dendritic cells (DCs), which are critical players in both innate and adaptive 
immunity since they are the most potent antigen-presenting cells. Co-incubation 
experiments result in enhancement or inhibition of dendritic cell maturation and IL-12 
or IL-10 induction (Borchers et al., 2009). IL-12 is a proinflammatory cytokine that can 
induce a TH1 response. TH1 cells, also known as Tdth (delayed type hypersensitivity), 
are involved in cell mediated immune responses such as destruction of intracellular 
bacteria, some types of delayed hypersensitivities, autoimmune diseases and the 
rejection of organ transplants. Mohamadzadeh et al., 2005 investigated the effect of L. 
gaseri, L. johnsonii and L. reuteri on human myeloid dendritic cells (MDCs). 
Lactobacilli exposed MDCs secreted high levels of IL-12 and IL-18 but not IL-10. 
MDCs activated with lactobacilli clearly skewed CD4+ and CD8+ T cells to TH1 and 
Tc1 (cytotoxic) polarization. Such strains promoting DCs to regulate T cell responses to 
cytotoxic pathways could be particularly advantageous as vaccine adjuvants, in 
infectious diseases and malignancy. 
In contrast, in other situations such as autoimmune disease or inflammatory 
disorders, the inhibition of certain cytokines might be desirable. For example, IL-10 
exhibits an impressive ability to inhibit the production by CD4 T cells (TH1 and TH2 (T 
helper cells)) and macrophages of both inflammatory cytokines (IL-1, IL-8 and TNF-α 
(tumor necrosis factor- α)) and those inducing cell mediating cytotoxicity (IL-2 and 
IFN-γ). Moreover, IL-10 production by DCs can induce regulatory T cells important for 
induction of tolerance. Hoarau et al., 2006 found that the supernatant from the culture of 
Bifidobacterium breve C50 could induce human dendritic cell (DC) maturation with 
high IL-10 and low IL-12 production. Analogically to B. breve, L. rhamnosus resulted 
in low IL-12 and IL-18 production by mature DCs, which could explain anti-
inflammatory effect of the strain in gastrointestinal disease and allergy (Braat et al., 
2004). 
 
1.1.2.2 Antimicrobial effect of probiotic bacteria 
The ability of lactobacilli to produce antimicrobial substances has historically long 
been used to preserve foods. Fermentation reduces the amount of available 
carbohydrates and results in a range of small molecular weight organic molecules that 
exhibit antimicrobial activity. The biological significance is believed to be of 
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amensalism, a means of one bacterium gaining advantage over another competing 
microbe (Ouwehand and Vesterlund, 2004). 
Homofermentative lactobacilli ferment hexoses exclusively to lactic acid, while 
heterofermentative to equimolar amounts of lactic acid, acetic acid / ethanol and CO2 
(Kandler and Weiss, 1986). Acids have been shown to diffuse passively through the cell 
membrane. After entry into the cytoplasm they dissociate into protons and charged 
derivatives to which the cell membrane is impermeable. The intracellular accumulation 
of protons leads to internal acidification which reduces the activity of acid-sensitive 
enzymes and damages proteins and DNA. The accumulation in the cytoplasm of the 
anionic moiety of the dissociated organic acids was suggested to affect the cellular 
physiology through a chelating interaction with essential elements (de Guchte et al., 
2002). Limit pH values under which bacteria do not grow are species dependent: 
Pseudomonas aeruginosa, Listeria monocytogenes, Brevibacterium lineus and 
Micrococcus spp (5.5-5.6); Escherichia coli, Klebsiella pneumoniae and Proteus 
vulgaris (4.4); Salmonella typhi (4.0-4.5); Salmonella paratyphi, Vibrio 
parahaemolyticus, Bacillus cereus, Clostridium botulinum, Enterococcus spp. (4.5-4.9); 
Lactobacillus spp. (3.8-4.4); Staphylococcus aureus (4.0); Lactococcus lactis (4.3-4.8) 
(Nemcova, 1997). In addition to its antimicrobial property due to the lowering of the 
pH, lactic acid functions also as a permeabilizer of the Gram-negative bacterial outer 
membrane (Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica serovar 
Thyphimurium) (Alakomi et al., 2000). The permeabilizing capacity of lactic acid can 
promote the antimicrobial activity of other fermentative metabolites that are too 
lipophilic or too large to effectively penetrate the intact Gram-negative bacterial outer 
membrane but that could possibly do so in the presence of lactic acid. Makras et al., 
2006, observed that the antibacterial activity of L. acidophilus, L. amylovorus, L. casei 
Shirota and L. rhamnosus GG against Salmonella enterica serovar Typhimurium was 
solely due to the production of lactic acid. However, the antibacterial activity of L. 
johnsonii and L. plantarum was due to the production of lactic acid and a non-
proteinaceous, heat-stable inhibitory substance, which was only active in the presence 
of lactic acid.  
Hydrogen peroxide (H2O2) is one of the toxic derivates of oxygen generated by 
lactic acid bacteria growing aerobically (Otero and Nader-Macias, 2006). The 
bactericidal effect of hydrogen peroxide is owing to its strong oxidizing effect on the 
bacterial cell: sulfhydryl groups of cell proteins and membrane can be oxidized 
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(Ouwehand and Vesterlund, 2004). Colonization of the urogenital tract by H2O2 
producing lactobacilli has been found to decrease the acquisition of human immune 
deficiency virus type 1 (HIV-1) infection (Martin et al., 1999), chlamydial and 
gonorrhea infection (Wiesenfeld et al., 2003). 
Lactobacilli produce a wide variety of antibacterial peptides. The peptide 
bacteriocins are inhibitory active at concentrations in the nanomolar range, and cause 
permeabilization and leakage of intracellular components in sensitive cells. They are 
commonly classified into three groups: class I, e.g. nisin, includes lantibiotics; class II, 
e.g. pediocin, small heat stable-peptides; and class III, e.g. helveticin J, large heat-labile 
proteins (Parente and Ricciardi, 1999). By definition, lactobacilli bacteriocins are 
extracellularly released primary or modified products of bacterial ribosomal synthesis 
and their inhibitory spectrum is in many cases limited to bacteria closely related to the 
producing strain (Nes and Holo, 2000). Only a few bacteriocins with wide inhibitory 
spectrum have been reported. L. plantarum strains isolated from the brine of spoiled 
black olives produced bacteriocins which inhibited the growth of Gram-positive 
(Enterococcus faecalis, L. casei, Streptococcus pneumoniae) and Gram-negative 
bacteria (Escherichia coli and Pseudomonas aeruginosa) (Todorov and Dicks, 2005). L. 
plantarum, L. pentosus, L. rhamnosus and L. paracasei isolated from boza, a Balkan 
beverage, produced bacteriocins active against L. casei, Enterococcus faecalis, 
Escherichia coli and Pseudomonas aeruginosa (Todorov and Dicks, 2006). L. 
delbrueckii, isolated from Bulgarian yellow cheese, produced bacteriocin active against 
Listeria monocytogenes, Staphylococcus aureus, Enterococcus faecalis, Escherichia 
coli, Yersinia enterocolitica and Y. pseudotuberculosis (Miteva et al., 1998). A 
bacteriocin called bulgarican produced by L. bulgaricus inhibited the growth of Bacillus 
spp, Proteus spp, Salmonella spp, Staphylococcus spp, Streptococcus spp, Clostridium 
spp, Pseudomonas spp, Sarcina spp, Seratia spp, Lactobacillus spp and E. coli 
(Nemcova, 1997). 
Bacteriocin production is growth associated: it usually occurs throughout the growth 
phase and ceases at the end of the exponential phase or sometimes before the end of 
growth. A decrease of bacteriocin titre usually follows. This may be related to 
adsorption on producer cells or to degradation by proteases (Parente and Ricciardi, 
1999). Bacteriocin production and activity are deeply affected by the type and level of 
the carbon, nitrogen and phosphate sources, cations and surfactants (De Vuyst, 1994; 
Parente and Ricciardi, 1999). Low bacteriocin activities (800AU/ml; 200AU/ml; 
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200AU/ml) were recorded when growing L. plantarum in BHI (Brain Heart infusion), 
M17 (medium for lactic streptococci) and 10% soy milk, respectively. The strain 
produced the highest activity of its bacteriocin (25 600 AU/ml) in MRS broth (Todorov 
and Dicks, 2005). Furthermore, growth at optimal temperature usually results in optimal 
bacteriocin production (Todorov and Dicks, 2005). Some lactic acid bacteria produce 
more than one bacteriocin. L. plantarum produced high levels of plantaricin S during 
log phase and also produced another bacteriocin (plantaricin T) with a different activity 
spectrum in late stationary phase (Jiménez-Díaz et al., 1993). Another strain of L. 
plantarum was found to produce two two-peptide bacteriocins. The complementary 
peptides were most active when combined than when present individually (Anderssen et 
al., 1997). On the other hand a given bacteriocin can be produced by several strains or 
species. De Vuyst, 1994, screened 21 nisin producing and 6 non-producing strains of 
Lactococcus lactis. Nisin titres varied from 1 to 1886 IU/ml. 
Another mechanism of lactobacilli antimicrobial activity involves the secretion of 
cell-cell signalling molecules produced in the course of interference with competing 
bacteria. In 2002 Gan et al. described inhibition of surgical S. aureus implant infection 
by secreted biosurfactant by L. reuteri (formerly L. fermentum). Four years later, 
Laughton et al., 2006, investigating the communication events between L. reuteri and S. 
aureus, found that lactobacilli could attenuate the pathogenic bacteria by changing the 
gene expression and inhibiting factors of virulence like superantigen-like proteins of S. 
aureus due to production of signal molecules.  
 
1.1.2.3 Probiotic bacteria in allergic diseases 
Some gastrointestinal abnormalities have been observed in children with atopic 
eczema. These have included histological and functional abnormalities of the gastric 
epithelium, mild degrees of jejunal villous atrophy with eosinophil infiltration and 
oedema of the lamina propria, low jejunal mucosal IgA plasma cell counts in the 
duodenal mucosa, increased gastrointestinal permeation. Caffarelli et al., 1998, 
suggested that such gastrointestinal abnormalities could precede atopic eczema and even 
play a role in the aetiology of the skin disease by allowing allergic sensitisation as a 
result of increased antigen entry through the damaged mucosa. Kalliomaki et al., 2001a, 
suggested a crucial role of the balance of indigenous intestinal bacteria for the 
maturation of the human immunity to nonatopic mode. Reduced ratio of bifidobacteria 
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to clostridia at neonatal age preceded the later development of atopic sensitisation. 
Atopic subjects had more clostridia (3.8-22.9 x 107 vs 1.8-6.1 x 107) and tended to have 
fewer bifidobacteria (0.4-7.6 x 109 vs 2.5-14.6 x 109) in their stools than nonatopic 
subjects. These finding initiated investigation of the therapeutic effect of oral 
bacteriotherapy on atopic disease. Kalliomaki et al., 2001b, reported that Lactobacillus 
GG (LGG) was effective in prevention of early atopic disease in children at high risk. 
LGG was given prenataly to mothers who had at least one first-degree relative (or 
partner) with atopic eczema, allergic rhinitis or asthma, and postnataly for six months to 
their infants.  The frequency of atopic eczema in the probiotic group was half that of the 
placebo group. In 2003 Rosenfeldt et al., observed that L. rhamnosus and L. reuteri at a 
dose of 1010 cfu of each strain given in combination for 6 weeks to 1- to 13-year-old 
children with atopic dermatitis resulted in experienced improvement of the eczema in 
56% of the patients. In 1997 Majamaa and Isolauri demonstrated the favourable effect 
of LGG administered to infants with atopic eczema and cow’s milk allergy. LGG was 
added in their extensively hydrolysed whey formula in a concentration of 5x108 cfu/g 
formula. The clinical score of atopic dermatitis improved significantly during the 1-
month of treatment. The median concentration of faecal tumour necrosis factor-alpha 
decreased significantly in this group, from 709 pg/g (91 to 1131 pg/g) to 34 pg/g (19 to 
103 pg/g), but not in those receiving the extensively hydrolysed whey formula only. 
Treatment of pregnant mothers and their high-risk infants with a combination of 
probiotics (LGG, L. rhamnosus, B. breve, and Propionibacterium freudenreichii subsp. 
Shermanii) and prebiotic (galacto-oligosaccharides) showed no overall preventive effect 
on allergic diseases by age of 2 years but tended to reduce IgE-associated atopic 
diseases. The increase of the proportion of asymptomatic infants showed that probiotics 
seemed not to affect sensitization per se but regulated the path from sensitization to 
clinical disease (Kukkonen et al., 2007). 
In contrast to the discussed findings, Kopp et al., 2008, have shown that probiotic 
LGG had no preventive effect on the development or severity of atopic disease in 
infants (2 years old) at high risk.  Instead there was a significantly higher risk of ≥5 
episodes with wheezing bronchitis in the LGG group, as compared with placebo.  
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1.1.2.4 Probiotics in inflammatory bowel disease 
The main characteristics of inflammatory and autoimmune diseases are tissue 
destruction and functional impairment as a consequence of immunologically mediated 
mechanisms which are principally the same as those functioning against pathogens. One 
of the main explanations for autoimmune phenomena is based on various infections 
capable of initiating the process in genetically predisposed individuals. Increased 
interest in infectious agents as causes of chronic diseases was awaken by the discovery 
of Helicobacter pylori as a causative agent of stomach ulcer, chronic gastritis and 
probably also of gastric cancer. Infection with intestinal pathogens such as Salmonella, 
Shigella and Yersinia can trigger autoimmune reactions in joints and other organs. 
Diseases with autoimmune features such as rheumatic fever and acute 
glumerulonephritis may develop after streptococcal infection (Tlaskalová-Hogenová et 
al., 2004). Dysregulation of intestinal immune response to normal bacterial flora was 
suggested to play a crucial role in inflammatory bowel disease (IBD). Duchmann et al., 
1995, observed that lamina propria mononuclear cells (LPMC) isolated from inflamed 
intestine but not peripheral blood mononuclear cells (PBMC) of IBD patients with 
active inflammatory disease strongly proliferated after co-culture with sonicates of 
bacteria from autologous intestine. LPMC from adjacent non-inflamed intestinal areas 
of the same IBD patients and PBMC or LPMC isolated from non-inflamed intestine of 
controls and patients with IBD in remission, in contrast, did not proliferate. PBMC or 
LPMC which had been tolerant to bacteria from autologous intestine, however, strongly 
proliferated after co-culture with bacterial sonicates from heterologous intestine. These 
study shows that tolerance selectively exists to own but not to foreign intestinal flora 
and that tolerance is lost in intestinal inflammation. 
Crohn’s disease and ulcerative colitis are two distinct clinical forms of inflammatory 
bowel disease, characterised by chronic relapsing intestinal inflammation. Decreased 
levels of Bifidobacterium and Lactobacillus strains have been described, whereas raised 
counts of Bacteroides and Enterococcus species are found in inflamed mucosa of 
patients with IBD (Borchers et al., 2009). Because of potential of certain probiotic 
strains to influence the intestinal microbial balance, improve mucosal barrier function, 
and modulate immune responses, there have been numerous clinical trials of probiotic 
supplementation in IBD patients. Cui et al., 2004, have investigated the effect of 
bifidobacteria in patients with ulcerative colitis (UC). Thirty patients received treatment 
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with sulphasalazine and glucocorticoid and then were randomly administered 
bifidobacteria or placebo (starch) for eight weeks. Three patients (20%) in the probiotic 
group had relapses during the 2-month follow-up period, compared with 14 (93.3%) in 
the placebo group. The concentration of the faecal lactobacilli and bifidobacteria has 
been significantly increased in the probiotic treated group. The anti-inflammatory 
cytokines were elevated in comparison with the control group. Kruis et al., 2004, 
compared the efficacy in maintaining remission of the probiotic Escherichia coli strain 
Nissle and established therapy with mesalazine in patients with UC. 327 patients 
received either the probiotic drug or mesalazine. The study lasted for 12 months. 
Analysis revealed relapses in 40/110 (36.4%) patients in E. coli Nissle group and 
38/112 (33.9%) in the mesalazine group. Consequently the efficacy of the probiotic E. 
coli Nissle in maintaining remission was equivalent to the gold standard mesalazine in 
patients with UC.  
Gupta et al., 2000, demonstrated efficacy of LGG (1010 cfu during 6 months) in four 
children with mildly to moderately active Crohn’s disease. There was a significant 
improvement 1 week after starting LGG, which was sustained through the study period. 
Median pediatric Crohn’s disease activity index scores were 73% lower than baseline. 
Intestinal permeability improved in an almost parallel mode. Two years later Guandalini 
et al., 2002, confirmed the favourable effect of LGG in four children with active 
Crohn’s disease.  
In Crohn’s disease, the potent proinflammatory cytokine (TNF-α) seems to play a 
pivotal role in the pathogenesis of altered mucosal immune function. Anti- TNF-α 
monoclonal antibody therapy has shown a beneficial response associated with clinical, 
endoscopic and histological remission. Basing on that data, Borruel et al., 2002, 
obtained ileal specimens at surgery from patients with Crohn’s disease. Mucosal 
explants from each specimen were cultured for 24h with non-pathogenic E. coli, L. 
casei, L. bulgaricus or L. crispus. The number of CD4 cells and release of TNF-α by 
inflamed Crohn’s disease mucosa was significantly reduced by co-culture with L. casei 
or L. bulgaricus; changes induced by L. crispus or E. coli were not significant. None of 
the bacteria induced changes in non-inflamed mucosa.  
Although the described studies were promising, the treatment of IBD with probiotic 
preparations proved to be difficult. The reports of Schultz et al., 2004, and Rolfe et al., 
2006, suggested no benefit of LGG, E. coli Nissle, VSL#3, Saccharomyces boulardii on 
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induction or maintenance of remission to patients with Crohn’s disease. Limited 
evidence that probiotics may reduce UC activity was reported by Mallon et al., 2007. 
Findings are too variable to allow firm conclusions concerning the effectiveness of 
specific probiotics in IBD and allergic diseases. A possible explanation is that human 
responses to probiotic treatment might differ depending on the composition of the 
individuals’ flora (Borchers et al., 2009).  
 
1.1.2.5 Probiotic bacteria in colon cancer  
The development of colon cancer is a multistage process that occurs when 
accumulation of mutation in certain protooncogenes and tumour suppressor genes leads 
to a cancer initiation (Wollowski et al., 2001). Probiotic bacteria have been investigated 
extensively in model systems for their ability to prevent mutations. In vitro assay 
systems using streptomycin-dependent strains of Salmonella typhimurium (TA98 and 
TA100) have shown antimutagenic activity of L. bulgaricus, Streptococcus 
thermophilus, L. helveticus and L. acidophilus against 2-(2-furyl)-3-(5-nitro-2-furyl) 
acrylamide, 4-nitroquinoline-N-oxide, 2-aminofluorene, N-methyl-N-nitro-N-
nitrosoguanidine (MNNG), 3,2-dimethyl 1-4-amino-biphenyl and faecal mutagenic 
extracts from cats, monkeys and dogs (Hosono and Kashina, 1986; Bodana and Rao, 
1990; Nadathur et al., 1994). L. bulgaricus was found to prevent 1, 2-dimethylhydrazine 
(DMH) induced DNA breaks in the colon of rats, whereas S. thermophilus was not 
effective (Wollowski et al., 1999). Treatment of mice with L. casei resulted in a 
reduction of induced by MNNG DNA damage in gastric and colonic mucosal cells. The 
percentage of cells remaining intact, were distinctly higher in the lactobacilli treated 
group (68 +/- 19) than in the group receiving only MNNG (45 +/- 17) (Pool-Zobel et al., 
1993). L. acidophilus, L. gasseri, L. confuses, S. thermophilus, Bifidobacterium breve 
and Bifidobacterium longum were antigenotoxic toward MNNG and DMH (Pool-Zobel 
et al., 1996). The strain of L. bulgaricus, known as the “I. Bogdanov strain 
tumoronecroticance 51 (“LB-51”ATCC 21815) was reported to possess antitumor 
effects in vivo on transplantated tumors in mice (Sarcoma 180, Ehrlich’s solid 
carcinoma, melanoma, melanosarcoma B-16, plastocystoma MOPS 315, 
adenocarcinoma ACATOL) (Popova et al., 1993).  
The involvement of multiple mechanisms and factors in the prevention of 
carcinogenesis by probiotics has been suggested:  
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(i) Dose dependent antimutagenicity of probiotics was found by Pool-Zobel et al., 
1996. The authors observed that 1010 viable probiotic cells / kg body weight of rat 
were antigenotoxic, while one half of this dose resulted in a loss of protective 
activity. 
(ii) The antimutagenicity of probiotic bacteria was reported to be growth related. 
Wollowski et al., 2001, suggested that in the linear growth phase, a profound 
increase in antimutagenic activity occured, which decreased in the stationary 
growth phase. 
(iii)In the process of fermentation the probiotic bacteria form short-chain fatty acids 
that lead to a decrease in the pH of the colon content, associated with a reduced 
incidence of colon cancer. Depending on the nature, quantity and the 
fermentability of the indigestible polysaccharides reaching the colon, the relation 
of short-chain fatty acids acetate, propionate and butyrate can vary. Butyrate may 
directly enhance cell proliferation in normal cells and apoptosis in transformed 
cells (Wollowski et al., 2001). 
(iv) Peptides released from milk proteins, mainly caseins, might be responsible for the 
antimutagenic activity of fermented milks (Matar et al., 1997). 
(v) Probiotic bacteria were shown to decrease the activity of nitroreductase and β-
glucuronidase (bacterial enzymes promoting production of mutagenic substances 
in the colon). Furthermore, probiotic ingestion was shown to stimulate cytochrome 
P450 activity and glutathione transferase activity in colon cells. The latter is an 
important enzyme involved in detoxification (Wollowski et al., 2001). 
(vi) Probiotic bacteria were reported to bind mutagenic compounds in the intestinal 
lumen that correlated with decreased concentration of mutagens in the urine and 
faeces (Orrhage et al. 1994, and later Hirayama and Rafter, 2000). 
(vii) Yogurt may exert antitumor activity by enhancement of regulatory immune 
mechanisms, mediated by a larger number of IgA, TNF-α and IL-10 cytokines that 
favour the apoptosis mechanisms and immune down regulation (Perdigon et al., 
2002). 
 
1.1.2.6 Probiotic bacteria in diarrhoea 
One of the main applications of probiotic bacteria has been the treatment and 
prevention of diarrhoea: acute antibiotic-associated diarrhoea, including severe 
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intestinal infections such as Clostridium dificile; rotavirus diarrhoea in premature 
infants, newborns and children; nosocomial diarrhoea. 
In 1987 Gorbach et al. reported that LGG was efficacious in terminating relapsing 
colitis due to C. difficile. Other studies (Arvola et al., 1999; Vanderhoof et al., 1999) 
reported beneficial co-administration of LGG (109 to 1010) and antibiotics to children, 
aged from 2 months to 12.8 years, for the treatment of acute infections of the upper or 
lower respiratory tract, urinary tract, soft tissues, or skin. LGG reduced the incidence of 
and duration of diarrhoea, stool frequency, and watery or soft stool consistency. The co-
administration of rehydration solution and LGG was an effective treatment for acute 
rotavirus diarrhoea in young children (1 month to 3 years of age) (Rautanen et al., 1998; 
Guandalini et al., 2000). Analogically, L. reuteri (1010 to 1011 cfu) was effective as a 
therapeutic agent in rotavirus diarrhoea in children (6 to 36 months of age) hospitalised 
with acute diarrhoea (75% rotavirus). The mean duration of watery diarrhoea after 
treatment was 1.7 days in the L. reuteri group and 2.9 days in the placebo group.  On 
the second day only 26% of the patients receiving L. reuteri had watery diarrhoea 
compared with 81% of those receiving placebo (1997 Shornikova et al.). 
Supplementation with LGG (Szajewska et al., 2001), Bifidobacterium bifidum and S. 
thermophilus (Saavedra et al., 1994) reduced significantlty the incidence of nosocomial 
rotavirus gastroenteritis in infants and children hospitalised for reasons other than 
diarrhoea. LGG proved to be useful also as a prophylactic measure to control diarrhoea 
in undernourished children (Oberhelmen et al., 1999). L. acidophilus fermented milk 
appeared to prevent radiotherapy-associated diarrhoea in female patients, suffering from 
gynaecological malignancies and scheduled for internal and external irradiation of the 
pelvic area (Salminen et al., 1988). Evaluating the evidence by type of acute diarrhoea 
Sazawal et al., 2006, suggested that probiotics significantly reduced antibiotic 
associated diarrhoea by 52%, reduced the risk of traveller’s diarrhoea by 8%, and that of 
acute diarrhoea of diverse causes by 34%. Probiotics reduced the associated risk of 
acute diarrhoea among children by 57% and by 26% among adults. The protective effect 
did not vary significantly among the probiotic strains Saccharomyces boulardii, L. 
rhamnosus GG, L. acidophilus, L. bulgaricus, and other strains used alone or in 
combination of two or more strains. 
Several possible mechanisms by which probiotics reduce the duration of diarrhoea 
have been suggested. Probiotics inhibit the adhesion of rotavirus by modifying the 
glycosylation state of the receptor in epithelial cells via excreted soluble factors (Freitas 
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et al., 2003). The presence of probiotics also prevents the disruption of the cytosceletal 
proteins in the epithelial cells, caused by the Escherichia coli, which leads to improved 
mucosal barrier function and reverse of the increased the secretion of electrolytes 
(Resta-Lenert and Barret, 2003).  
 
1.1.2.7 Probiotics in bacterial translocation 
Bacterial translocation is defined as the passage of both viable and non-viable 
microbes and microbial products such as endotoxin across an even anatomically intact 
intestinal barrier (Wiest, 2005). The bacteria translocating most readily are those usually 
classified as facultative intracellular pathogens – i.e. those that are able to survive 
outside the white blood cells but are also able to resist phagocytic killing. Classic 
examples are Salmonella species and Listeria monocytogenes. Particularly aerobic and 
facultative anaerobic Gram-negative bacteria from the indigenous gastrointestinal flora, 
including E. coli, K. pneumoniae, other Enterobacteriaceae, P. aeruginosa, Enterococci 
and Streptococci, were found to translocate in high numbers to the mesenteric lymph 
nodes (MLNs) (Wiest, 2005). Curiously, these species are those most frequently 
associated with complicating infections in severely ill hospitalized and particularly 
cirrhotic patients. Although intestinal anaerobic bacteria outnumber aerobic bacteria by 
100:1 to 1000:1 (Steffen et al., 1988), anaerobes have been reported to translocate only 
in extreme circumstances such as athymic, lethally irradiated or severely burnt rodents 
(Wiest, 2005). Bacterial overgrowth is one of the main factors promoting bacterial 
translocation. Reduced gastric acidity (e.g. due to use of antiacids) and predominantly 
gastrointestinal dysmotility (Nieuwenhuijs et al., 1998) can promote bacterial 
overgrowth). Increased intestinal permeability is another permissive factor for bacterial 
translocation. It has been observed in patients with burns, traumas, following 
cardiopulmonary bypass, elective or emergency vascular surgery, hemorrhagic shock, 
jaundice, indomethacine, parenteral endotoxin, as well as in intensive care patients 
(Wiest, 2005). Today it is accepted that many septic complications after injury are due 
to colonization of the oropharynx, the tracheobronchial tree, and the upper 
gastrointestinal tract or to translocation of potentially pathogenic microorganisms in the 
lower gastrointestinal tract. Among organ donors with a median hospital stay of only 
1.9 days (range from 6 hours to 8 days) bacterial cultures were positive in 67% most 
often in mesenteric lymph nodes, lung, liver and spleen. Endotoxin was found in 
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abdominal fluids in approximately 50% of the cases, in peripheral blood in 20%, and in 
portal blood in 10% - before any changes were evident in the intestinal wall. Increased 
intestinal permeability was described as early as 16 to 24 hours after moderate burns. 
The first peak of endotoxin occured in the blood of patients about 12 hours after burns 
(Bengmark and Gianotti, 1996). 
Selective gut decontamination has been used to prevent infection by eradicating the 
potential pathogens, while preserving the normal anaerobic flora. It is performed usually 
with non-absorbable antibiotics, such as gentamycin, tobramycin, polymyxine, 
amphotericin B or cefotoxin and its major targets are Enterobacter, Pseudomonas, 
Acetobacter and yeast (Nathens et al., 1999; Bengmark, 2003).  
Another concept to decrease bacterial translocation is by using probiotics such as 
lactobacilli. Lactobacilli may play an important role in the preservation of the natural 
biological equilibrium of the intestinal tract and the growth modulation of the other 
groups of bacteria. Promising results have been observed in treatment of critically ill 
patients with a combination of pre- and probiotics. Pancreatic necrosis and infections 
are strong determinants of organ failure and poor outcome in severe acute pancreatitis 
(Isenmann et al., 1999). Olah et al., 2002 have reported that supplementary L. 
plantarum (109 cfu) together with a substrate of oat fiber was effective in reducing 
pancreatic sepsis and the number of surgical interventions. Infected pancreatic necrosis 
and abscesses occurred in 1 of 22 patients in treatment group, compared with 7 of 23 in 
the control group. 
Bacterial and fungal infections occur after liver transplantation during the first post-
operative month in up to 85% of cases despite of extensive antibiotic treatment and 
selective digestive tract decontamination. The incidence of postoperative infections after 
liver transplantation in 95 patients (Rayes et al., 2002) was compared among three 
different groups, all supplied with early enteral nutrition: (a) a standard formula plus 
selective bowel decontamination, (b) fiber-containing formula plus living L. plantarum, 
and (c) fibre-containing formula plus heat killed L. plantarum. The patients who 
received living lactobacilli plus fiber developed significantly fewer bacterial infections 
(13%) than the patients with selective bowel decontamination (48%). Three years later a 
further improved outcome after liver transplantation was reported using early enteral 
nutrition supplemented with a mixture of four LAB (1010 Pediococcus pentosaceus, 
Leuconostoc mesenteroides, L. paracasei subsp. paracasei and L. plantarum) and four 
fibers (2.5g of each betaglucan, inulin, pectin and resistant starch, totally 10g/dose) or 
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fibers only. The incidence of post-operative bacterial infections was reduced to 48% 
with fibers and 3% with lactobacilli and fibers (Rayes et al., 2005). 
 
1.1.2.8 Probiotics in wound infection 
Topical application of probiotic bacteria on the skin and around all perforations of 
the skin by foreign materials such as tubes, drains, tracheostomies etc. is receiving 
increasing interest (Bengmark, 2003). Moreover, the use of lactobacilli could be of 
particular interest for treatment of burns. Local treatment with L. plantarum of infected 
with P. aeruginosa burn wounds in a burned-mouse model demonstrated inhibition of 
P. aeruginosa, improvement in tissue repair, enhanced phagocytosis and a decrease in 
apoptosis (Valdez et al., 2005). Burned patients (with infected and non-infected second 
and third degree burns) treated with Lactobacillus plantarum cultures showed the same 
recovery as the ones treated with silver sulphadiazine (Peral et al., 2009).  Another 
proof of the anti-infective role of certain probiotic bacteria in the healing process of 
wounds can be found in the study of Nikitenko from 2007. The presence of Bacillus 
subtilis in the wounds of patients following surgery for open or closed limb fractures 
reduced the possibility of suppuration. 
 
1.1.3 Probiotics as live vaccine delivery vehicles 
The potential of lactic acid bacteria to deliver protective antigens at different 
mucosal surfaces has been investigated. Three lactic acid bacterial hosts have been 
evaluated as potential vaccine vehicles: Lactococcus lactis, a cheese starter strain, as a 
prototype of non-colonising strain; lactobacilli which are able to colonise given body 
cavities; and Streptococcus gordonii, an oral commensal bacterium of human origin 
(Mercenier et al., 2000).  
Successful immunization of mice resulting in a protective immune response with a 
lactic acid bacterium in the absence of additional adjuvants was achieved using the non-
toxic C fragment of tetanus in the cytoplasm of Lactococcus lactis (Wells et al., 1993). 
This positive result initiated a series of experiments, in which TTFC was invariably 
used as the model antigen. Many variables (e.g. strain dependence, expression levels, 
cellular location of expression and immunization schemes) were tested. Experiments 
showed that recombinant L. plantarum, expressing TTFC was equally capable of 
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eliciting an immune response, irrespective of the site of expression (intracellularly, 
anchored to the cell wall or secreted) however with different response levels. While 
cell-surface presentation required lower antigen doses to be immunogenic, the highest 
IgG serum antibody titres were obtained with the strain producing large amounts of 
TTFC in the cytoplasm (Reveneau et al., 2002). A comparison between L. plantarum 
and L. casei, in which TTFC was expressed either as an intracellular or a surface 
exposed protein, showed that regardless of the route of administration (oral or 
intranasal), responses were always higher when L. plantarum was used as delivery 
system (Shaw et al., 2000). These results confirm that Lactobacillus strains can 
differentially influence the immune system. 
Independent studies showed that TTFC – specific response following intranasal as 
well as oral immunization could be obtained with L. plantarum expressing TTFC 
intracellularly (Reveneau et al., 2002; Shaw et al., 2000). Endpoint titres were higher 
following intranasal immunizations than following oral immunizations. To determine 
whether these immunizations require live bacteria, a comparison was made between 
mice that were immunized intranasally with either live or mitomycin-C treated bacteria 
(Grangette et al., 2001). This reduced the viable count from 109 to 0.5 x 105 colony 
forming units (cfu). No differences were observed in total serum TTFC-specific IgG 
level but protection levels as determined by neutralizing tetanus antibody levels, were 
eightfold lower with mitomycin-C treated bacteria than with live bacteria. 
In parallel to this work, Steidler et al., 1998, demonstrated that host immune 
responses could be enhanced by co-delivery of IL-2 and IL-6 and TTFC. The approach 
of delivering cytokines with known modulatory properties was continued by the 
construction of recombinant L. lactis strains secreting murine IL-10 (Steidler et al., 
2000). The authors showed that these strains were able to prevent or treat inflammation 
in 2 murine colitis models. Notably this effect was obtained with much lower doses of 
IL-10 than those required when the cytokine was used as free polypeptide. Steidler et 
al., 2003 further constructed a safe (no antibioresistance marker and chromosomally 
integrated transgene) biologically contained strain secreting human IL-10 and a human 
intervention trial (targeting IBD) with this strain has been conducted (Braat et al., 
2006). 
Lactobacilli are currently under investigation not only in active vaccination but also 
in passive vaccination. Passive vaccination requires the delivery of pathogen- or toxin-
neutralising agents – most commonly immunoglobulins. Complete immunoglobulins 
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are complex molecules that are difficult to produce in bacteria and strategies are 
therefore being developed for secretion and cell-wall anchoring of single-chain 
polypeptides, which comprise only the binding domain of the immunoglobulins. The 
value of this technique was shown in the study of Krüger et al., 2002. Vectors encoding 
a single-chain Fv (scFv) antibody fragement, which recognizes the streptococcal antigen 
I/II (SAI/II) adhesion molecule of Streptococcus mutans, were constructed and 
expressed in L. zeae. The scFv antibody fragments expressing bacteria agglutinated 
SAI/II-expressing S. mutans in vitro and reduced S. mutans bacterial counts and caries 
after administration to a rat model of dental carries. Chang et al., 2003, have engineered 
natural human vaginal isolates of L. jensenii to secrete two-domain CD4 (2D CD4) 
proteins. The secreted 2D CD4 recognized a conformation-dependent anti-CD4 
antibody and bound HIV type 1. Lactobacillus-derived 2D CD4 inhibited HIV-1 entry 
into target cells in a dose-dependent manner. 
 
 As described above, there are fundamental differences between various probiotic 
strains. The expected clinical effects from the use of different probiotic strains are most 
various and conclusions cannot be made from one strain to another. Unravelling the 
mechanisms underlying the complex interactions among probiotic and pathogenic 
bacteria as well as among probiotic bacteria and host microflora, epithelial cells and 
immune cells would permit better understanding of the probiotic effect. 
 
1.2 Examples of delivery systems containing lactobacilli and other probiotic 
bacteria 
The reliability of probiotic strains in terms of quality and functional properties is 
dose-dependent. The supply of a probiotic organism in a number of 107 or lower to the 
site of administration is generally regarded as being too small for significant probiotic 
effects to be expected (Bengmark, 2003). Consequently, the ability of probiotic 
organisms to withstand the adverse conditions, encountered in industrial processes, and 
the natural barriers of the host, has become essential for the development of probiotic 
applications such as bacteriotherapy, live vaccines and probiotic foods. Stability of 
probiotic organisms can be demonstrated only if they still show metabolic activity after 
storage and intake by a host. Based on the biological limitations of microorganisms 
originating from their genetically determined metabolic peculiarities and their 
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phenotypes, two ways for manufacturing of probiotic products can be used (Viernstein 
et al., 2005; Alpas et al., 2000; Niemela et al., 1994). One way is the direct use of fresh, 
concentrated, refrigerated or frozen probiotic cultures (e.g. yogurts, ice creams), which 
has the advantage of very limited loss of viability, but the limit of a short storage time 
(four to six weeks). The other way relies on the principle of transforming bacteria in a 
dormant state by drying techniques (e.g. freeze-drying). When freeze-drying is applied 
to microorganisms the cellular function is suspended temporarily because it is cut off 
from the metabolic activities that are mediated by the action of water (Souzu, 2004). 
This permits their preservation for a longer period of time and gives them further 
flexibility for incorporation into delivery systems. Alternative drying processes with 
lower costs, such as spray drying, fluidized bed drying and vacuum drying have been 
considered (Santivarangkna et al., 2007a). A major drawback of cellular dehydration is 
related to a higher risk of physical cellular damage (Viernstein et al., 2005).  
 
1.2.1 Drying processes 
1.2.1.1 Spray drying 
In heat drying processes like spray drying, probiotic cultures are atomized into a 
flow of hot air, e.g. 150-200ºC. Inactivation of cells can occur due to both high 
temperature and dehydration. Temperature inactivation of an atomized cell suspension 
at the beginning (constant drying rate period) is limited by the evaporative cooling 
effect. At the following stage (falling drying rate period), the temperature inactivation of 
the cells increases depending on the drying parameters such as inlet/outlet air 
temperatures, residence time and feed rate. The outlet air temperature at which the 
product leaves the drying chamber is believed to have a major impact on bacterial 
viability (Santivarangkna et al., 2007a, 2008). It was found that below 64ºC damaging 
sites are structures contained in or making up the cell membrane. For temperatures of 
65ºC and above, ribosome and/or protein denaturation as well as cell wall damage may 
be responsible for the thermal death (Teixeira et al., 1997). 
1.2.1.2 Fluidized bed drying 
Heat inactivation can be minimized and easier controlled by using relatively low air 
temperatures in fluidized bed drying. Cells must be entrapped or encapsulated in 
support materials such as skim milk, potato starch, alginate and casein as only 
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granulable materials can be dried (Santivarangkna et al., 2007a). However, the water 
activity of the support material can pose an osmotic shock, the severity of which 
determines the bacterial viability. When L. plantarum cells were mixed with extremely 
desiccated casein powder (aw≤0.1), viability of the mix did not exceed 2.5% (Mille et 
al., 2004). 
 
1.2.1.3 Vacuum drying 
Vacuum drying is a suitable process for heat sensitive materials. Since the drying 
operates under vacuum, moisture can be removed from the materials at a low 
temperature. For example while the boiling point of water at 100 kPa (1 atm) is 100ºC, 
at 1 kPa it is approximately 8ºC. Moreover, the oxidation reactions during drying can be 
minimized for oxygen sensitive bacteria (Santivarangkna et al., 2007a). The process, 
however, was reported to result in lower viability of L. acidophillus compared to freeze-
drying (Conrad et al., 2000). Investigating the mode of inactivation of L. helveticus due 
to vacuum drying, Santivarangkna et al., 2007b, found that cell injuries were attributed 
to damage in the cell membrane and wall. 
 
1.2.1.4 Freeze drying 
Freezing and drying, also called lyophilization, is the appropriate choice for 
production of dry but viable cells of most microorganisms. Cellular damage of 
microorganisms is considered to be accumulated result, which might have been initiated 
during the freezing stage, but detected after dehydration. Detrimental chemical 
reactions, which could be induced in the state of lower water activity, might continue 
through the early drying stage to the storage period (Souzu, 2004). 
Bacterial tolerance to freezing and drying is related to cell growth phases and 
growth environments. Generally, logarithmically growing cells are very susceptible to 
freezing and freeze-drying damage. For example, Escherichia coli cells grown at two 
different temperature ranges showed an increasing tolerance to freeze-thawing and 
freeze-drying when cell growth approached its stationary phase (Table 1.3). It is related 
to increasing structural stability of the cellular membrane accordingly to the cell growth 
phases (Souzu, 2004). 
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Table 1.3 Viability of freeze-thawed or freeze-dried E. coli cells cultivated at different temperatures 
and differing growth phases. 
Freeze-dried
ºC H -5ºC -30ºC
2 * 4 3.8 4
3 ** 52.3 50.4 24.9
5 *** 93.9 92.5 38.6
8 * 6.2 5.7 0.2
20 ** 52.2 35.5 8.2
48 *** 82.8 51.4 47.8
37
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Cultivations Survival of CellsFreeze-thawed
 
(H) Incubation time (*) Cells growing in logarithmic; (**) Early stationary; (***) Stationary phase 
(after Souzu, 2004) 
 
The growth temperature as well as the sugar substrates in the growth medium can 
also affect the tolerance of cells to freeze-drying and their survival during storage. 
Incubation of E. coli cultures at 42ºC promoted significantly higher survival rate of the 
organism during freeze-drying, compared to incubation at 30ºC (Souzu, 2004). The 
lowest decrease in viability of L. bulgaricus cells after freeze-drying was obtained when 
the organism was grown in the presence of mannose. Moreover, L. bulgaricus clearly 
survived better during storage when cells were grown in the presence of fructose, 
lactose or mannose rather than glucose (the standard sugar in the growth medium) 
(Carvalho et al., 2004). 
Cell concentration of the final suspension before freeze-drying has a significant 
effect on the survival rate. A high concentration of the cells prevents suitable heat 
conductivity in the freeze-drying process and thus hinders the effective sublimation of 
ice crystals and also desorption of unfreezable water molecules in the drying process 
through formation of a thick interstitial network in the specimen. On the other hand, if 
cell suspensions are too low concentrated, the cell viability might be lowered through 
lack of the protective effects generated by mutual contact of the cells. Besides, cells can 
be dispersed by the stream of the water vapour formed during ice crystal sublimation 
because they lack effective networks. As a result many cells will be lost in the process 
(Souzu, 2004). 109-1010cfu/ml was found to be an optimal bacterial cell concentration 
resulting in the highest survivability during freeze-drying in the studies of Costa et al., 
2000 and Palmfeldt et al., 2003. 1012 cfu/ml was reported to be too concentrated for 
freeze-drying of L. bulgaricus and S. thermophilus (Bozoglu et al., 1987). 
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Cellular damage is thought to be caused by increasing concentration of solutes or 
growth of ice crystals in the cells during extracellular and intracellular freezing. The 
cooling rate is one of the most important factors during freezing. Since the cytoplasm of 
a cell generally remains unfrozen at -10ºC to -15ºC, extracellular ice crystals usually 
form first and the solutes will be concentrated in a smaller volume of unfrozen water. 
Cells will lose water to maintain the osmotic equilibrium between the inside and the 
outside of cells if the rate of freezing is very low. Consequently the alteration in the 
intra- and extracellular solutions produced by ice formation outside the cells results in 
cell dehydration. For this reason, the slow freezing injury is referred to solution effect 
injury (Mazur 1970). In contrast, if the cooling rate is so high that cells are not able to 
lose water rapidly enough to maintain the osmotic equilibrium, intracellular ice 
formation will occur. Different views on intracellular ice formation have been reviewed 
by Santivarangkna et al., 2008. The phenomenon was hypothised to result from 
damages or defects developing in cell membranes. Consequently, an optimal cooling 
rate which to be low enough to avoid intracellular ice formation but high enough to 
minimize solution effects could to prevent cellular damage. Moreover, hydrophilic and 
cell membrane–penetrable materials might be anticipated as protective substances. 
Glycerol, dimethylsulfoxide and small molecular weight sugars have been described to 
repress ice crystal generation or retard its growth in solution, during slow and rapid 
freezing. No ice crystals have been observed in red blood cells or in yeast cells, in the 
presence of 30% glycerol, and their viability after thaw was almost 100% (Souzu, 
2004). 
Another factor in maintaining cell viability would be to stabilize the cell membrane 
itself. The cell membrane is the principal site of inactivation during freezing as well as 
during dehydration. In normal membranes phospholipids are hydrated and adsorb 
various amounts of water depending on the type of phospholipid. The removal of the 
water increases opportunities of van der Waals’ interaction among the hydrocarbon 
chains. In membranes in which the relative water content is less than 0.25 g H2O per g 
dry material, it may cause large lateral compressive stresses in the plane of membrane 
and phospholipids are likely to undergo phase transition (Wolfe, 1987), e.g. from liquid 
crystalline (Lα) to gel phase (Lβ). Consequently at a physiological temperature where 
lipids are usually fluid and molten, the lipids may begin changing to gel phase during 
drying. In other words, there is a corresponding gradual increase in the membrane phase 
transition temperature (Tm, the midpoint of a transition temperature range) as the water 
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content decreases. This increase in Tm generally becomes detectable at water contents 
less than approximately 0.2 g H2O per g dry material (Santivarangkna et al., 2007a). In 
probiotic cultures, Tm of L. plantarum was reported to shift from 4ºC in hydrated cells to 
20ºC in dried cells (Linders et al., 1997) and from 35 to 40ºC in L. bulgaricus (Oldenhof 
et al., 2005). Cell membranes stability is increasing through the contribution of 
hydrogen bonding and hydrophobic bonding between membrane materials and water 
molecules in the system. Protective substances for freeze-drying with hydrogen bond 
forming ability are classified into low molecular weight compounds such as amino 
acids, organic acids, sugars, and sugar alcohols, and high weight substances such as 
proteins, polysugars, polyvinylpyrrolidone, and synthetic polymers (Leslie et al., 1995; 
Carvalho et al., 2002; Linders et al., 1997; Souzu, 2004; Oldenhof et al., 2005). Table 
1.4 summarizes substances used in varying combinations as cryoprotectants for 
probiotics. 
 
Table 1.4 Cryoprotectants for probiotic microorganisms. 
Adonitol Skim milk powder Dimethylsulphoxide Polyethyleneglycol
Alpha-tocopherol Maltodextrin Gelatine Sucrose
Beta-glycerophosphate Malt extract Glucose Sorbitol
Bovine albumin Mannitol Glycerol Trehalose
Calcium alginate Milk fat Glycogen Tween
Calcium carbonate m-Inositol Lactose Xanthan gum
Casein hydrolysate Na-alginate L-ascorbic acid Yeast extract
Carnithine Na-glutamate L-asparagine Whey powder
Dextran Pectin L-cystein
 
(after Viernstein et al., 2005) 
 
Determination of the endpoint of the process of freeze-drying is another critical 
aspect. Higher moisture content in the probiotic products has damaging effect during 
storage, but overdrying of living cells results not only in impairment of cellular 
constituents but also triggers chemical reactions including aminocarbonyl reaction, free 
radical generation, and unbalanced metabolism (Souzu et al., 2004). Zayed et al., 2004 
showed that a residual water content of 2.8 to about 5.6% improved survival rate of 
lyophilized L. salivarius during storage. On the other hand, removing water from the 
dried cells (0.0% moisture content), as well as higher moisture content (8.8%) resulted 
in viability decrease of 44 and 17% in 1 week and 72 and 92% in 7 weeks, respectively. 
Carefully handled freeze-dried products can theoretically withstand storage, over a 
wide temperature range. However, oxidative reactions, enzymatic evolution, and 
chemical degradation containing fatty acid oxidation are highly temperature dependent, 
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especially at higher temperatures (Souzu, 2004). Thus storage in a moderate 
temperature range, most reliable between 5 and 10ºC, will improve the cell viability 
over a longer storage period. Light and oxygen are also detrimental (Kandler and Weiss, 
1986; Viernstein et al., 2005). 
 
1.2.2 Powders 
The described drying techniques are used to obtain probiotic powders, which on the 
other hand can be used for sachet fillings and hard gelatine capsule fillings. Other 
vehicle forms for probiotic powders are pellets and tablets. It should be taken into 
consideration that each further processing step is related to further bacterial death. 
 
1.2.3 Capsules 
Hard (gelatine) capsules are an ideal dosage system for powders and granules. The 
capsule filling process is a process with low physical impact on the bacterial material. 
Film coating may be applied to the capsules for protection against gastric juice or for 
controlled release. Huyghebaert et al., 2004 suggested the usage of enteric pre-coated 
capsules to overcome problems of destabilization of heat and moisture sensitive 
materials such as lyophilized biomaterials (peptides, proteins, bacteria). 
 
1.2.4 Tablets 
Tablets are still the most common pharmaceutical dosage form, which relative to 
other dosage types are inexpensive and could be therefore of interest for the production 
of probiotic bacteria loaded tablets. In general, tabletting is not the ideal process for 
products comprising viable bacteria, because the excess of forces used to compact a 
powdery or granulated pre-mixture cause physical damage into the dry cell walls and 
membranes (Viernstein et al., 2005). Chan and Zhang, 2002, examined the effect of 
compression pressure (from 0 to 180 MPa) on the viability and sublethal injuries of L. 
acidophilus. The authors found that there was no significant loss in cell viability up to 
the pressure of 30 MPa. However, compaction even at these low pressures still caused 
some damage to the wall of the cells. When the compression pressure was increased 
from 30 to 90 MPa, there was a gradual increase in loss of cell viability. When the 
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pressure exceeded 90 MPa, damage not only occurred to the wall of the cells but also to 
their membranes and cell viability decreased almost linearly with the compression 
pressure. Consequently in order to minimize the cell loss by compression, the pressure 
should be as low as possible but simultaneously enough to ensure tablet rigidity for 
further handling. 
It should be taken in consideration that different strains exhibit different tolerance to 
pressure. Maggi et al., 2000 demonstrated that three out of ten strains, including L. 
salivarius and L. gasseri, maintained high viability during tabletting. Formulation 
components can play an important role in microorganism inactivation or protection. 
Blair et al., 1991 found that the type of consolidation during compaction (plastic or 
brittle fracture) influenced survival of Staphylococcus aureus and Enterobacter cloacae. 
Plastic deforming microcrystalline cellulose (Avicel PH-101) caused the greatest 
bacterial lethality at low compression forces compared to lactose monohydrate and 
maize starch. Different studies showed that skim milk powder, sodium alginate, 
hydroxypropylmethylcellulose acetate succinate (HPMC-AS) and HPMC-phtalate can 
be used as matrix-forming excipients providing resistance of microorganisms (L. 
acidophilus, L. fermentum) to compression, gastric juice and during storage (Stadler and 
Viernstein, 2003; Klayraung et al., 2009). Inclusion of probiotic-specific substrates 
known as prebiotics, could be a strategy to improve survival at the site of 
administration. A prebiotic is defined as a non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and / or activity of 
probiotic bacteria (Gibson and Roberfroid, 1995). Inulin and its hydrolysate, 
oligofructose are among the most common prebiotics (Roberfroid, 2007).  
 
1.2.5 Pellets via extrusion / spheronisation processing 
From a current standpoint extrusion / sheronisation is not considered an optimal 
option for the stabilisation of bacteria (Viernstein et al., 2005). The physical impact on 
the biological materials, including rise in temperature and mechanical stresses: 
compaction pressure and shear forces (Ghebre-Sellassie, 1989; Vervaet et al., 1995), 
can exceed the limits of cell survival. Another important factor affecting the viability, 
particularly when fresh bacterial culture is used, is the progressive decrease of water 
content. Drying of bacteria starts with the mixing of bacteria with powders promoting 
high osmotic pressure (Mille et al., 2004) and continues during extrusion and 
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spheronisation (Ghebre-Sellassie, 1989; Vervaet et al., 1995). When osmotic shock is 
applied via powders, the osmotic gradient induces water exit, but little or no solute can 
penetrate into the cell. The volume variation of the cell can result in cell death (Mille et 
al., 2004). A strain-dependent survivability has been documented in literature. Kim et 
al., 1988, carried out extrusion / spheronisation experiments using lactic acid bacteria 
incorporated in a medium of skim milk, food grade cellulose and glycerol. The authors 
showed that cell morphology could influence the survival rates of different bacterial 
cultures. They reported no loss of viability of Streptococcus cremoris and Pediococcus 
acidilactici (both cocci) in pellets after 1 week storage at room temperature, but a loss 
of viability of more than 1 log unit of L. plantarum (rod-shaped) in pellets stored at the 
same conditions. Storage at 4ºC for a period of 35 to 76 days resulted in stable viability 
of all organisms (109cfu/g for S. cremoris, 1011cfu/g for L. plantarum and P. 
acidilactici). Contrary to Kim et al., 1988, Huyghebaert et al., 2005a, reported a 
detrimental effect of extrusion / spheronisation processing on Lactococcus lactis. The 
authors used L. lactis culture as a granulation fluid of microcrystalline cellulose 
containing sodium carboxymethyl cellulose, low substituted hydroxypropyl cellulose 
and starch. They observed a 2 log viability decrease of the organism after pelletisation 
and drying and a further 2 log decrease in 1 week of storage at room temperature and 
low relative humidity. The authors suggested that the shear developed during 
granulation and mainly during extrusion / spheronisation combined with rise in 
temperature (30-40ºC) could be responsible for the drop of viability and sublethal injury 
which accumulated later in drying and storage. 
 
1.2.6 Coated solid particles 
A protective coating around particles loaded with microorganisms is an approach for 
stabilization. However, the coating temperatures should not exceed the bacterial growth 
temperature range and the solvent for coating materials can only be water. Furthermore, 
the hygroscopic nature of the dry particles will result in the uptake of moisture from the 
coating suspensions. Therefore water removal is essential to avoid degradation 
processes in the solid particles (Viernstein et al., 2005). In 2005 Huyghebaert et al., (b), 
evaluated in vitro the enteric properties of different polymers for coating of Lactococcus 
lactis layered pellets. Aqoat AS-HF and Eudragit S provided good gastro-resistant 
properties. However, coated pellets had to be cured at elevated temperatures (60ºC), 
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which made the polymers improper for the coating of the temperature sensitive 
organisms. On the other hand, Eudragit L30D-55 and a mixture of Eudragit FS30D / 
L30D-55 dissolved at a pH lower than 6.8 and consequently bacteria would be 
subjected to the bile salts present in the jejunum. In contrast Eudragit FS30D dissolved 
at pH 7.2-7.4 and consequently the bacteria would only be released in the most distal 
part of the ileum. Further investigation of the effect of Eudragit L30D-55 and Eudragit 
FS30D on the viability of L. lactis showed a better survivability of the organism during 
processing and in simulated gastric acid when coated with Eudragit FS30D 
(Huyghebaert et al., 2005c). 
 
1.2.7 Immobilisation techniques 
Cell immobilisation approaches represent an alternative strategy in which cells are 
immobilised within biocompatible polymers and have been shown to offer many 
advantages for biomass and metabolite productions compared with free-cell (FC) 
systems such as: high cell density, retention of plasmid bearing cells, improved 
resistance to contamination, stimulation of production and secretion of secondary 
metabolites and physical and chemical protection of the cells (Scannell et al., 2000). 
Most widely the immobilisation techniques rely on entrapment of cells within porous 
polymeric matrix such as alginate, chitosan, κ-carageenan, gellan, agarose and gelatine 
(Lacroix et al., 2005). Another method is the adhesion or adsorption to a preformed 
matrix, such as sintered glass, porous glass, ceramic particles, silicon rubber (Gonçalves 
et al., 1992; Bergmaier et al., 2003), that imitates what takes place in a natural 
environment where cells are almost always associated with surfaces and grow in biofilm 
(Dunne, 2002).  
Cells produced by immobilisation technology especially when combined with 
continuous cultures exhibit changes in growth, physiology as well as morphology 
compared with the cells produced during conventional free cell cultures. Cachon et al., 
1998, observed differences in cell physiology (redox state, enzymatic pool and 
intracellular pH) between free and immobilised L. lactis. A shift in the metabolic 
pathway from homofermentative to heterofermentative has been observed during 
continuous cultures with immobilised L. plantarum, accompanied by morphological 
changes in immobilised cells from the normal rod shape to the coccoid shape (Krishnan 
et al., 2001). Moreover, an increased tolerance of immobilised cells (IC) to alcohols, 
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phenols, antibiotics or quaternary ammonium sanitizers was observed (Lacroix et al., 
2005). Trauth et al., 2001, explained the phenomenon of increased cell tolerance of the 
IC used in continuous fermentations, by possible modification of the cell membrane and 
physiology, and by cell proximity in a saturated matrix. In colonised beads the cell 
density inside the gel matrix could reach 400g dry weight / l, or about 1 x 1012 cell/ml 
(Trauth et al., 2001). However, the cell growth in colonised gels is non-uniform. It is 
characterised with a high cell density region near the bead surface with a thickness 
varying from 100 to 400µm (Massen et al., 1994; Lacroix et al., 2005). The growth 
inhibition in the central part of the gel bead may be explained by the combined effect of 
high product concentration and low pH, promoting the undissociated form of lactic acid, 
which has been associated with inhibition of lactic acid bacteria (Massen et al., 1994).  
Massen et al., 1994, observed a pH decline from the surface (pH 4.35) to the centre (pH 
3.8) of the gel bead. Actually, the development of steep inhibitory product, pH and 
biomass gradients can induce a non-specific stress adaptation (Lacroix et al., 2005).  
Bacterial immobilisation has also been shown to improve bacterial viability during 
storage and protect bacteria from adverse processes, such as freezing and freeze-drying 
and hostile environments, such as gastric juices. Bifidobacterium longum strains 
encapsulated in κ-carrageenan microcapsules showed no difference in the cell 
populations during refrigerated storage of 30 days, while non-encapsulated 
bifidobacteria showed a decline of 0.54 and 0.63 log units for the same period of time. 
A higher stability was reported for L. bulgaricus cells immobilised in alginate beads 
compared with FC during storage of frozen dairy desserts (90% vs 40% survival) (Sheu 
et al. 1993). Protective effect of alginate bead microenvironment to L. plantarum during 
freeze-drying was reported by Kearney et al., 1990. In this study the incorporation of 
cryoprotective agents (adonitol and skim milk) in the alginate solution increased the 
protective effects of immobilisation and gave survival rates as high as 85.9% compared 
with 64.6% for FC lyophilized with the same cryoprotectants. Cui et al., 2000, prepared 
Bifidobacterium bifidum–loaded alginate microparticles. The obtained microcapsules 
were further suspended in poly-l-lysine solution to cross-link the particles. Alginate as 
well as poly-l-lysine treatment enhanced highly the survival of bifidobacteria in 
simulated gastric environment (ca. >108 vs. <103 cfu/g). Screening of different 
microencapsulation conditions of L. acidophilus showed that highest protection of the 
organism at low pH (pH 2) and high bile concentration (1%) was obtained with 1.8% 
(w/v) alginate, 109 cfu/ml, 30 min hardening in 0.1 CaCl2 and capsule size 450 µm 
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(Chandramouli et al., 2004). Sun and Griffiths, 2000, reported a protective effect of 
immobilization of Bifidobacterium infantis into gellan-xanthan beads to simulated 
gastric juices. At pH 2.5 the viable count of free cells dropped from 1.23 x 109 to an 
undetectable level (<10 cfu/ml) in 30 min, while the viable count of the immobilised 
cells decreased by only 0.67 log cycle in the same time period. Microencapsulation of 
Bifidobacterium longum B6 and Bifidobacterium infantis carried out by spray drying the 
cell suspension containing the test organism and 10% of carrier material of gelatine, 
soluble starch, skim milk or gum arabic, had also protective effect on bifidobacteria to 
simulated gastric and bile environment (Lian et al., 2003). 
Finally, the application of IC technology could be advantageous to conventional 
technologies by development of products retaining high concentrations of metabolic 
active bacteria with prolonged viability and enhanced tolerance to various stresses.  
 
1.3 Aim of the Thesis 
The aim of the Thesis was the incorporation of Lactobacillus spp. into different 
dosage forms to evaluate their viability and antibacterial activity against multi-resistant 
bacteria. 
 
1.4 Organization of the Thesis 
The first part of the experimental work aimed to provide evidence of the viability of 
Lactobacillus spp. (L. plantarum, L. rhamnosus GG and L. bulgaricus) and a spore form 
of B. subtilis from non-processed bacteria to coated dosage forms (i.e., mini-tablets, 
pellets and their coated forms). The development of the dosage forms involved: 
evaluation of processing techniques (freeze-drying, tabletting, pelletization and coating) 
and excipients (skim milk, microcrystalline cellulose, inulin ST and HP, lactose, 
Eudragit FS30-D) on the bacterial viability and comparison of the relative viability 
among the bacterial strains, regarding their processibility and stability throughout 
storage. 
 
The second part of the experimental work aimed to produce calcium alginate 
beads able to deliver Lactobacillus spp.  (L. plantarum, L. rhamnosus GG, L. bulgaricus 
and L. lactis) with preserved viability and antibacterial activity. Four types of beads, 
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containing entrapped (E), surface and entrapped (ES), surface (S) and concentrated 
surface and entrapped lactobacilli (CES) were prepared and physically characterised. The 
antibacterial activity of lactobacilli cultures before and after immobilization and freeze-
drying and throughout storage was studied in relationship to the viable number of 
lactobacilli. Multi-resistant clinical isolates (methicillin-resistant Staphylococcus 
aureus, vancomycine-resistant Enterococcus faecalis, VIM-2-metalo-β-lactamase 
producing Pseudomonas aeruginosa and CTX-M-15-β-lactamase producing strains: 
Escherichia coli and Klebsiella pneumoniae) were used as indicator strains.   
 
 The third part of the experimental work aimed at the development of calcium 
alginate films, containing Lactobacillus plantarum with preserved and stable viability 
and antibacterial activity suitable for topical administration. Calcium alginate films 
containing both entrapped and surface lactobacilli were produced with different calcium 
concentrations. Films were physically characterized for mechanical, adhesive properties 
and lactobacilli release. The viability and antibacterial activity of L. plantarum was 
studied before and after processing and during 6 months of storage. A multi-resistant 
clinical isolate, VIM-2-metalo-β-lactamase producing Pseudomonas aeruginosa, was 
used as the indicator strain. To test the in vivo activity of the immobilized lactobacilli, a 
rat model of burn injury was used in which burned skin contaminated with P. 
aeruginosa was exposed to L. plantarum loaded films. 
 
The parts mentioned were designed based on the state-of-the-art presented in the 
first chapter of the thesis, that is divided into two parts, one related to the identification 
of the advantages of using the bacteria in routine applications and a second part related 
to the most relevant dosage forms to deliver Lactobacillus bacteria to humans. 
 
The last chapter (chapter 5) summarizes the main aspects that have been learnt from 
all the work, as concluding remarks. 
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CHAPTER 2 
 
EVALUATION OF THE VIABILITY OF LACTOBACILLUS 
SPP. AFTER THE PRODUCTION OF DIFFERENT SOLID 
DOSAGE FORMS 
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2.1 Introduction 
The continuous consumption of probiotics has been claimed to promote the health 
condition of individuals (Halpern et al., 1991). Among a vast number of probiotic 
microorganisms, strains from genus Lactobacillus have been used for centuries. A 
common problem found in the use of microrganisms is that the number of viable cells 
determines the probiotic effect and thus, the stability of the microorganisms in probiotic 
products is critical. Often, the starting point is in the order of 109 cells per gram of 
product. However, in storage this number decreases dramatically several orders of 
magnitude reaching 103 – 106 cfu/g (Temmerman et al., 2003). Other major concern is 
the decrease of the number of viable cells in the stomach (Toumola et al., 2001). 
Different strategies for stabilization of cells have been taken into consideration, 
namely tabletting of freeze-dried bacteria (Maggi et al., 2000, Stadler and Viernstein, 
2003), production of pellets (Huyghebaert et al., 2005a) or encapsulation of bacteria 
(Chan et al., 2005). Some authors have considered coating the dosage forms to observe 
their disintegration in the intestine (Chen, 2007). Communality to the works is that cells 
have to be harvested from the culture media and dried (often by freeze-drying) in 
protective matrices and, thus, enabling processing, increasing preservation and allowing 
easy reconstitution of the bacteria at the site of administration (e.g. gastrointestinal 
tract). 
 
2.2 Materials and Methods 
2.2.1 Materials 
The examined probiotic strains were Lactobacillus plantarum ATCC 8014, 
Lactobacillus rhamnosus strain GG ATCC 53103, LGG, Lactobacillus delbrueckii 
subsp. bulgaricus CIP 101027 and Bacillus subtilis ATCC 6633. 
Two types of inulin have been used (ST, a standard inulin and HP, a high 
performance inulin, respectively Raftiline ST and HP, Orafti, Oreye, Belgium). Other 
excipients used were microcrystalline cellulose (Avicel PH101, FMC Corporation, 
Cork, Ireland), lactose monohydrate (Granulac 200, Meggle, Wasserburg, Germany), 
skim milk (SM, Difco, Detroit, MI), glycerol (Sigma-Aldrich Chemie, 
Steinheim,Germany), (D+) mannose (Merck, Darmstadt, Germany), glyceryl 
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monostearate (Sigma-Aldrich Chemie) and poly(meth)acrylate derivative (Eudragit 
FS30D, a colonic coat, Evonik-Röhm, Darmstadt, Germany). 
 
2.2.2 Methods 
2.2.2.1 Strains and culture conditions 
Lactobacilli were cultivated overnight on de Man-Rogosa-Sharpe (de Man et al., 
1960), (MRS, Biokar Diagnostics, France) agar and in broth at 37ºC. B. subtilis was 
incubated on plate count agar (PCA, Biokar Diagnostics, Beauvais, France) at 37ºC for 
two-weeks to produce spores. The two-week old cultures were then concentrated up to 
107cfu/ml in sterile distilled water and pasteurized in a water bath at 80ºC for 20 min to 
acquire spore suspensions without vegetative forms. 
 
2.2.2.2 Freeze-Drying 
Cells, harvested from overnight broth cultures (20ml) by centrifugation at 4000 rpm 
for 20 min at 4ºC (Jouan CR411, Jouan, Saint Nazaire, France), were washed twice in 
Ringer’s solution and re-suspended in equivalent volumes of reconstituted skim milk 
(10%) or growth medium (MRS), containing 1% of glycerol or mannose as 
cryoprotectors. The suspensions were kept for 1h at room temperature prior to freezing 
at -80ºC for 24h (Carvalho et al., 2004). By analogy, the spores harvested by 
centrifugation were re-suspended in skim milk enriched with 1% glycerol and frozen 
immediately afterwards. The frozen samples were dried under vacuum at 0.035mbar for 
72h at room temperature (25ºC) (Christ LDC-1m Alpha 2-4, B. Braun, Biotech 
International, Melsungen, Germany). Water content and bacterial viability in the freeze-
dried powders were evaluated. 
 
2.2.2.3 Production of mini-tablets 
Lyophilizates of each bacterial strain were compressed to mini-tablets. The freeze-
dried cakes were ground in a mortar alone or together with different excipients in a ratio 
of 1:1 or 3:1 parts of the compaction aid, either inulin or microcrystalline cellulose 
(Table 2.1, upper part). The mixtures were compacted in a single punch tabletting 
machine (Korsh, Erweka Gmbh, Heusenstamm, Germany) fitted with 2.5 mm diameter 
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punches and die. The powders were compacted at 1, 2 and 5kN (25.5, 50.9 and 
127.3MPa) to produce tablets with an average weight of 6.75mg. The size (n=10), 
weight (n=10), crushing force (n=5) (European Pharmacopoeia 5, 2.9.8 (European 
Pharmacopoeia), tensile strength (Fell and Newton, 1970), density (n=10) (helium 
pycnometry, Accupyc 1330, Micromeritics, Norcross, GA), disintegration time (n=6) 
(European Pharmacopoeia 5, 2.9.1 (European Pharmacopoeia) and viable number of the 
mini-tablets were evaluated. 
 
2.2.2.4 Production of pellets 
Microcrystalline cellulose (10g) and lactose (40g) were blended in a planetary mixer 
(Kenwood-Chief, Kenwood, UK), for 5min. Then, 25g of inulin HP and 25g of skim 
milk (SM) were added to the mixture and the blending continued for another 5min. The 
overnight cultures of each Lactobacillus strain were tenfold concentrated by 
centrifugation and re-suspension of the cell pellets in tenfold smaller quantity of 
physiological saline. The concentrated lactobacilli cultures and B. subtilis spore 
suspension were then used as granulation liquids (30g), gradually added to the mixture 
of powders (pel 1, Table 2.1, lower part). The wet mass was extruded in a ram extruder 
(12.5 mm diameter, Lloyd K50, Lloyds Instruments Ltd. Fahernham, Hampshire, UK) 
at 400mm/min at a maximum force of 5kN through a 1 mm diameter die. The 
extrudates were spheronised in a spheroniser with a cross hatched plate (Caleva 230 
spheroniser, Caleva, Sturminster Newton, Dorset UK) for 10 min at 1000 rpm. Pellets 
were dried in a fluid bed drier (Strea, Niro-Aeromatic, Bubbendorf, Switzerland) at 
30ºC for 60 min prior to evaluation for size (laboratory test sieve analysis, Retsch, 
Haan, Germany, for 5 minutes), weight, force required to crush them (pellets were 
placed between two horizontal jaws, perpendicular to their movement and crushed, 
CT5, Engineering System, Nottm, UK) (European Pharmacopoeia 5, 2.9.8 (European 
Pharmacopoeia) disintegration time (European Pharmacopoeia 5, 2.9.1 (European 
Pharmacopoeia) and density (helium pycnometry). In order to evaluate the effect of 
increasing the amount of inulin in the pellets, a second formulation for L. plantarum 
only, was considered (pel 2, Table 2.1, lower part). 
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Table 2.1 Composition of Formulations (in parts). 
Lyophilizate Skim milk Inulin ST Microcrystalline 
cellulose Inulin HP
Tab 1 100
Tab 2 50 50
Tab 3 75 25
Tab 4 50 50
Tab 5 50 50
Tab 6 75 25
Bacterial 
suspension Skim milk Lactose
Microcrystalline 
cellulose Inulin HP
Pel 1 30 25 40 10 25
Pel 2 30 15 40 10 35
Formulations of pellets
Formulations of mini-tablets
 
 
2.2.2.5 Coating 
Both mini-tablets and pellets (100g) were coated with Eudragit FS30D (a coating 
material designed to deliver drugs to the colon), to obtain a 15% weight gain. Glyceryl 
monostearate (glidant) was added to 70ºC heated water and stirred at high speed for 
20min until a fine dispersion was obtained. After cooling down to room temperature 
this dispersion was slowly poured into the Eudragit FS30D dispersion while gently 
stirred with a magnetic stirrer. The coating dispersions were passed through a 0.5 mm 
sieve before use. A fluid-bed coating apparatus (Strea, Niro-Aeromatic, Switzerland) 
was operated at 30ºC, at a spray rate of 4 g/min and atomising pressure of 1.5 atm with 
a 1mm diameter nozzle. After coating both coated tablets and pellets were cured in the 
apparatus for 30 min at the same temperature as the coating process. 
 
2.2.2.6 Water content assay 
The water content of the dosage forms was determined gravimetrically in a moisture 
balance (Sartorious moisture analyzer, Goettingen, Germany). 300mg samples were 
dried to constant weight by infrared radiation at 105ºC. 
 
2.2.2.7 Viability of the microorganisms 
The number of viable cells or spores was determined by the agar plate method 
before and after freeze-drying, tabletting, pelletisation and coating, and throughout six 
months of storage. Samples of each dosage form were re-hydrated and serial dilutions 
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were plated in duplicate. The assessment of the survival rate of the microorganisms in 
the coated tablets or pellets was performed by submitting the coated tablets and pellets 
to a HCl solution (pH 1.5, at 37ºC for 2 hours) and then to a 0.05M phosphate buffer 
solution (pH 7.4, at 37ºC) (European Pharmacopoeia 5, 2.9.3 (European 
Pharmacopoeia).  
2.2.2.8 Storage conditions 
All dosage forms were kept in plastic tubes over silica gel in closed glass containers 
(desiccators), at 4ºC, for a maximum period of 6 months. 
 
2.3 Results 
2.3.1 Bacterial de-hydration 
 A comparison between the different processes of de-hydration of bacteria has 
proved the use of freeze-drying technique to obtain a higher viability when compared 
with other techniques (Meng et al., 2008). Initially the stabilizing capacity of two 
different protective media was tested. L. plantarum was freeze-dried (FD) in its growth 
medium, MRS broth, and in skim milk, both enriched with 1% of glycerol. The viable 
count decreased less than 1 log unit after FD and was comparable in both media. 
However, the MRS broth matrix was brittle and did not possess the good boosting 
properties of the milk. The results confirmed the reported suitability of milk as a 
protective matrix in the process of lyophilization of bacteria (Huyghebaert et al., 2005a, 
Carvalho et al., 2004). 
 In a different set of experiments the inclusion of glycerol and mannose in the 
formulation of the cakes was considered. After 2 months of storage the decrease of the 
bacterial viability after freeze-drying was comparable between cakes containing 
glycerol and mannose. 
The cakes produced by freeze-drying at room temperature (25ºC) for 24h showed 
residual moisture content of 6-7%, which decreased to 5% (48h) and to 2-3% after 72h, 
remaining constant afterwards. Thus, drying at room temperature was deemed 
convenient and considered in future cycles of drying.  
 Following these findings, cakes were prepared from bacteria harvested at maximum 
concentrations of 109cfu/ml for L. plantarum and LGG and 108cfu/ml for L. bulgaricus, 
and 107cfu/ml for B. subtilis spores in skim milk and glycerol. It was found that 1ml of 
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a bacterial or spore suspension in skim milk with glycerol was converting into 
approximately 0.1g of freeze-dried powder. Figure 2.1 shows the decrease of the 
number of viable bacteria from the moment of preparation of the bacterial suspensions 
(week -1: overnight cultures) until the end of storage (week 24). Week 0 refers to the 
beginning of storage immediately after freeze-drying. 
 L. plantarum and LGG showed a minor decrease of bacterial counts after drying, i.e. 
from 3.4 x 109 to 1.2 x 109cfu/ml and from 1.7 x 109 to 1.1 x 109cfu/ml respectively. L. 
bulgaricus was the most sensitive strain to drying: its viability dropped from 3.8 x 108 
to 0.5 x 108cfu/ml. The latter, as the other strains, have shown a constant viability over 
the 6 months of storage. The spores of B. subtilis were resistant to both processing and 
storage without any change in the survival rate (Figure 2.1). 
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Figure 2.1 Viability of freeze-dried bacteria during storage (mean and SD, n=3). 
(The first point in each line represents the number of viable bacteria in each suspension before  
freeze-drying) (■ L. plantarum; ▲ LGG;  L. bulgaricus; + B. subtilis). 
 
2.3.2 Tabletting 
The freeze-dried powders were converted into mini-tablets according to the 
formulations considered in Table 2.1 (upper part). The production of mini-tablets was 
designed to allow comparison with pellets as multi unit dosage forms, and also to 
impose high shear forces on the materials under compression. The results in Table 2.2, 
for one strain only, summarize the observations made for all strains, because: a) the 
results for 1kN compaction force applied were not significantly different from the ones 
observed for a 2kN force and thus are not shown, and b) the patterns observed for L. 
bulgaricus were identical to the ones observed with the other strains. 
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As anticipated the tablet’s height was dependent on the force applied to the 
materials: lower the force higher the height (Table 2.2). By filling the tablet dies 
manually it was possible to keep the weight of the tablets approximately constant for all 
batches. Even though, in some cases tablets were produced with a significant weight 
variation due to the poor flow ability of the powders (e.g. tab 4-6, inulin, Table 2.2) 
suggesting that this excipient may not be the most adequate for tabletting. Table 2.2 
(upper part) shows that microcrystalline cellulose had the best effect on tabletting by 
producing tablets with higher tensile strength whereas the inclusion of inulin in the 
formulations did not improve the properties of the frozen cakes (Table 2.2). The 
densities of the tablets were not indicative of a particular formulation. Changes on 
density (Table 2.2) were not related to the tensile strength nor to the tabletting force 
used failing to show a clear relationship between the porosity of the formed tablets 
(related to their density) and the number and intensity of bonds between particles 
(reflected by the tensile strength). The disintegration times of the tablets have shown 
that the presence of microcrystalline cellulose (tab 2 and 3, Table 2.2) in the formulation 
delayed the disintegration of the tablets (probably due to the formation of a matrix 
system) whereas tablets produced from freeze-dried cakes (tab 1, Table 2.2) did show 
the lowest disintegration times due to the high affinity for water of the lyophilizates. 
Tablets containing inulin have shown behaviour in between the previous ones due to the 
fact that inulin neither forms a matrix nor has affinity for water as the freeze-dried 
materials (tab 4-6, Table 2.2). 
 
Table 2.2 Summary of the properties of mini-tablets and pellets produced with L. bulgaricus and L. 
plantarum, respectively. 
2 1.00±0.03 6.04±0.42 30.5±6.0 7.77 1.502 2
5 0.83±0.05 5.96±0.26 30.9±1.6 9.49 1.403 4
2 7.06±0.77 10.04 1.609 7
5 7.72±0.54 11.43 1.842 11
2 1.04±0.03 6.41±0.49 42.9±3.7 10.51 1.901 6
5 0.86±0.02 6.32±0.21 42.4±8.5 12.56 1.812 8
2 1.12±0.05 6.85±0.92 26.3±3.2 5.98 1.890 6
5 0.92±0.10 6.11±0.58 27.9±3.8 7.73 1.532 6
2 1.14±0.07 7.19±0.45 33.8±1.5 7.55 1.531 3
5 1.04±0.06 6.71±0.85 30.7±0.9 7.52 1.732 4
2 1.11±0.05 7.04±0.42 24.8±4.6 5.69 1.683 3
5 1.00±0.07 7.14±0.50 32.7±7.4 8.33 1.508 6
1.18 3.50±0.23 5.0±0.2 1.462 8
1.04±0.04 
1.11±0.04
41.0±2.9 
49.8±0.1
L.
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A more distinctive difference between tablets was observed when the viability of 
each microorganism was considered. Figure 2.2 represents the log of cfu/g (colony 
forming unit per gram) of tablet mass as a function of time starting from the production 
of the freeze-dried bacteria (week -1), to the production of tablets (week 0) until the end 
of storage (week 24). 
A decrease of 1 to 2 log units in the bacterial viability was observed immediately 
after compression for all strains (e.g. 1.2 x 1010 to 7.8 x 108 cfu/g for L. plantarum, 1.0 x 
1010 to 2.5 x 108 cfu/g for LGG and 5.0 x 108 to 4.2 x 107 cfu/g for L. bulgaricus; 
average of results for tab 1, 4,5 and 6, Table 2.3), except of the spores (2.2 x 108 to 1.6 x 
108 cfu/g for B. subtilis spores; average of results for tab 1, 4-6, Table 2.3). Figure 2.2 
(tab 1, left column) shows that the viability of the micro-organisms in the freeze-dried 
powders was identical to the one observed for the mixtures containing inulin (tab 4-6, 
Figure 2.2). 
Looking at the B. subtilis behaviour it suggests that the spores are robust enough to 
support changes related to the formulation (inclusion of microcrystalline cellulose or 
inulin), to the force applied (1 to 5 kN) or to the proportion between the freeze-dried 
cake and the excipient (Figure 2.2, lower graphs). Moreover, the desiccated form 
remained stable for the period of observation (6 months, Figure 2.2). By contrast L. 
bulgaricus and LGG have shown major decreases of their viabilities, particularly when 
microcrystalline cellulose was used in the formulation. The presence of microcrystalline 
cellulose not only promoted a sudden decrease during compression of both micro-
organisms (e.g. 1.0 x 1010 to 2.3 x 107cfu/g for LGG and 5 x 108 to 3 x 106cfu/g for L. 
bulgaricus, tab 2 and tab 3), but was also unable to keep their stability, reaching a 
minimum by the end of the third month of storage below which detection was not 
possible (Figure 2.2, tab 2 and tab 3). 
L. plantarum was the most resistant to tabletting among the lactobacilli strains. Its 
viability decreased, when compacted alone or with inulin was less or equal to 1 log until 
the end of storage (Figure 2.2, upper graphics and Table 2.3) while the viability loss in 
the same formulations for LGG and L. bulgaricus reached 2 log units compared with the 
initial cell concentration after tabletting (Figure 2.2, middle graphics and Table 2.3). 
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Figure 2.2 Bacterial viability in mini-tablets during storage [log cfu/g]. The initial point in each graph represents the viable count in the freeze-dried powders before 
tabletting. (▲ 1kN; ■ 2kN; ○ 5kN) 
2.3.3 Pelletisation 
Pelletisation started by kneading the powders in the formulation with water. It was 
observed that a 1:1 mixture of skim milk and inulin resulted in a quickly solidifying 
mixture unsuitable for extrusion. Kneading of skim milk alone resulted in sticky to semi-
liquid mixture whereas kneading of inulin alone gave a sticky mass originating rod pellets 
after extrusion and spheronisation. These limitations were overcome by inclusion of 
lactose and microcrystalline cellulose in the formulations (pel 1 and pel 2, Table 2.1, 
lower part). 
Figure 2.3 shows the changes of the numbers of viable bacteria throughout the 
process of pelletisation. Pellets prepared according to Pel 1 formulation (Table 2.1, lower 
part) have shown a continuous decrease of the number of viable cells. Again, the most 
sensitive were the L. bulgaricus and LGG, resulting in a loss of viability of 
approximately 3 log units due to kneading, extrusion and fluid bed drying, but not 
spheronisation (Figure 2.3). The viability kept decreasing throughout storage (4.5 x 
106cfu/g to undetectable levels in four months for LGG and 1.8 x 105cfu/g to 
undetectable levels in one month for L. bulgaricus, ‘Pellets’, Table 2.3 and Figure 2.4). In 
the present study L. plantarum and, particularly B. subtilis were stable throughout the 
process of extrusion-spheronisation and subsequent drying (Figure 2.3) and in storage 
(4.1 x 109 and 1.7 x 109, L. plantarum, 8.0 x 106 and 13 x 106, B. subtilis, Table 2.3). As 
an attempt to confirm the positive effect of inulin on the bacterial viability, pellets with 
higher amount of inulin were considered (pel 2, Table 2.1, lower part). Increasing the 
content of inulin, with a concomitant decrease on skim milk content led to a destabilizing 
effect during storage, i.e., a 1 log unit decrease (at the end of the third month of storage), 
while the viable count in the first formulation remained constant during storage. This 
effect has also been observed in storage of pellets obtained by layering of L. lactis 
dispersions in skim milk and inulin over inert pellets (Huyghebaert et al., 2005c). 
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Figure 2.3 Bacterial viability during pelletisation (mean and SD, n=3). 
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Figure 2.4 Bacterial viability in non-coated pellets during storage (mean and SD, n=3). 
(■ L. plantarum; ▲ LGG;  L. bulgaricus; + B. subtilis) 
 
2.3.4 Coating 
Regarding the application of the coat for colonic delivery, a proper protection was 
reached when 15% coat (by weight gain) was applied. For this amount of coating material 
applied both tablets and pellets remained intact in acidic medium for 2 hours (HCl, 0.1N 
at 37ºC) with bacterial viability preserved in comparison to the uncoated cores. When the 
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tablets and pellets were placed in phosphate buffer solution (pH 7.4, 37ºC) they have 
disintegrated after 1.5 hours. 
Coating of both tablets and pellets with Eudragit FS30D caused an initial viability 
decrease, less than 1 log unit, when compared to the cores (‘Coated’ Table 2.3 and Figure 
2.5 a,b). It is interesting to point out that the viability during storage was not affected by 
coating, i.e. the viability profiles of coated tablets and pellets decreased as before of the 
uncoated tablets and pellets (‘Coated’ Table 2.3 and Figure 2.5 a,b). 
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Figure 2.5 Bacterial viability before and after coating and throughout storage (mean and SD, n=3) in a) 
mini-tablets (the first point in each line represents the viable count in the tablets before coating) and b) 
pellets (the initial point in each graph represent the viable count in the pellets before coating). 
(■ L. plantarum; ▲ LGG;  L. bulgaricus; + B. subtilis) 
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2.4 Discussion 
Previous tests have shown that processing of bacterial suspensions in the presence of 
components such as skim milk and glycerol ended up in high survival rates of bacteria in 
the resulting product (Huyghebaert et al., 2005a; Carvalho et al., 2004). Therefore, it was 
deemed convenient to incorporate one or more of these materials in the formulations at 
early stages of production. These materials by protecting (throughout processing) and 
nourishing the bacteria (upon release from the dosage form) promote high viability rates 
after processing. Inulin adds other advantages to the product, namely by reducing the risk 
of colonic cancer to the patient (Verghese et al., 2002, Roberfroid, 2000) and by 
providing enhanced filler and binding properties for direct compression of materials 
(Eissens et al., 2002). 
 
Table 2.3 Viability of the examined strains in the different pharmaceutical formulations (1) 
Storage at 4ºC Lyophilizates Mini-tablets Pellets Coated mini-
tablets (2)
Coated pellets 
(2)
[month] [cfu/g] [cfu/g] [cfu/g] [cfu/1,15g] [cfu/1,15g]
0 1,15E+10 7,82E+08 4,08E+09 7,50E+08 8,30E+08
L. plantarum 3 1,30E+10 3,01E+08 2,90E+09 3,00E+08 7,10E+08
6 5,00E+09 1,60E+08 1,70E+09 2,30E+08 5,25E+08
0 1,06E+10 2,53E+08 4,50E+06 3,50E+08 6,80E+05
LGG 3 1,30E+10 4,86E+06 1,30E+03 2,00E+07 0,00E+00
6 8,00E+09 1,20E+06 0,00E+00 3,45E+06 0,00E+00
0 5,00E+08 4,22E+07 1,75E+05 7,00E+06 6,50E+04
L. bulgaricus 3 3,50E+08 1,17E+06 0,00E+00 2,95E+06 0,00E+00
6 2,30E+08 3,78E+05 0,00E+00 2,50E+05 0,00E+00
0 2,20E+08 1,62E+08 8,00E+06 7,60E+07 5,00E+06
B. subtilis 3 1,45E+08 3,07E+08 1,20E+07 7,40E+07 5,75E+06
6 2,20E+08 2,59E+08 1,25E+07 8,10E+07 5,75E+06
Strains
 
(1) The represented values of viability are average values from the viabilities of the formulations of 
lyophilizates compacted alone or with inulin ST/HP. 
(2) 1.15g of coated material equals 1g of non-coated material. 
 
The fact that the cell numbers after drying remained in the same order of magnitude 
as in the overnight cultures suggests that on the one hand, adequate processing conditions 
were reached and, on the other hand, the viability of bacteria was more affected by 
changes in the water content present in the environment and particularly in the de-
hydration of the cells. Furthermore, the drying process is a key to high survival rates: FD 
allowed a higher survival than air drying, as observed throughout extrusion, for instance. 
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The consequent compaction of the freeze-dried bacteria showed higher survival rates 
of L. plantarum during compression and storage compared to LGG and L. bulgaricus. 
Moreover, L. plantarum demonstrated a higher survivability than the other lactobacilli 
when compacted with microcrystalline cellulose, which was unable to protect the 
bacterial cells from the forces exerted over them in the process of tablet formation and 
from the environment throughout storage. It is clear that bacterial cells differ in their 
susceptibility according to strains, species, growth conditions, suspending medium, 
freeze-drying and tabletting conditions. The genus Lactobacillus comprises more than 
100 species (Felis and Dellaglio, 2007) widely differing in biochemical, ecological and 
molecular-biological properties. This large variation is often reflected by the wide range 
of G+C content of DNA from 32 to 53 mol%, a span twice as large as usually accepted 
for a single genus, and by the lack of significant DNA/DNA homology between most of 
the species. L. plantarum, followed by LGG, exhibits a wide range of fermented 
carbohydrates, while L. bulgaricus ferments only a few carbohydrates, i.e. fructose, 
lactose and glucose. L. plantarum has been isolated from dairy products and 
environments, silage, sauerkraut, pickled vegetables, sour dough, cow dung and human 
mouth, intestinal tract and stools, and from sewage (Kandler and Weiss, 1986). LGG has 
been isolated from human intestinal tract (Gorbach et al., 1987) and L. bulgaricus is 
adapted to specialized niches, i.e. sour milk and cheese (Kandler and Weiss, 1986). Thus, 
it is not surprising that from all described characteristics of the three Lactobacillus spp. 
one can recognize that L. plantarum is less fastidious and more adaptive to different 
conditions than LGG and L. bulgaricus. These properties of L. plantarum could be the 
reason for its higher resistance to the different processing conditions (e.g. freezing, 
drying, compression forces and excipients). However, it is important to understand the 
mechanism of cellular injury, in order to recognise the effect of the different processes 
and excepients on the loss of viability. Morphological, biochemical and genetic studies 
are required to show possible changes brought by the variable conditions. 
The resistance of B. subtilis to freeze-drying and tabletting may be explained by the 
fact that the spores wall and structure could support shear, tension or compression forces 
generated in the process of compaction. The strain dependent stability in freeze-drying 
and tabletting were also discussed in several reports (Maggi et al., 2000; Stadler and 
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Viernstein, 2003). Some authors (Huyghebaert et al., 2005a) observed a drop of nearly 1 
log unit in the survival rate of the bioengineered L. lactis after its compaction (52MPa) 
into mini-tablets. In one week of storage a further 25% decrease in the viability at low 
relative humidity (RH) and a complete viability loss of viability at 60% RH was 
observed. However, the effect of pressure over bacteria is contradictory. Different 
conclusions were reached by other authors (Stadler and Viernstein, 2003) who did not 
observe a reduction of L. acidophilus (109 cfu/tablet) during six months of storage at 10 
or 20ºC. These authors considered a pressure of 25.5 to 63.7MPa. In a different study 
(Maggi et al., 2000) the authors described the different sensitivities of ten Lactobacillus 
strains to different excipients and processing conditions and observed a stable viability 
throughout one year. In both studies (Maggi et al., 2000, Stadler and Viernstein, 2003) 
the higher stability reported could be due not only to the individual strain characteristics 
but also to the dosage form. Both research groups prepared bigger tablets (10mm) than 
the ones discussed in the present work and, certainly the forces (namely shear forces) 
over individual particles or cells observed in tabletting are different and, consequently, 
differences should be expected regarding the performance of the bacteria.  
As anticipated an increase of the compaction force was generally reflected by an 
increase of the tensile strength, suggesting that the particulate powders deformed 
plastically under pressure. Direct compression of the freeze-dried cakes required the use 
of microcrystalline cellulose or inulin to overcome some technological problems of the 
cakes namely stickiness, poor flow or poor compaction properties. The presence of 
plastic materials (e.g., microcrystalline cellulose) is expected to affect the viability of 
bacteria because, by definition, these materials under pressure deform in all directions. 
On the other hand, materials that have some degree of brittleness, such as inulin (Eissens 
et al., 2002) can provide some degree of protection by accommodating some stresses due 
to compression forces. This may explain the poor protection provided by the 
microcrystalline cellulose on protecting the bacterial cells from the forces exerted over 
them in the process of tablet formation and from the environment throughout storage. 
 Pelletisation recurs traditionally to lactose and microcrystalline cellulose (Fielden et 
al., 1993). However, the above discussion has shown that microcrystalline cellulose has a 
deleterious effect on the stability of the microorganisms, thus it had to be kept at lower 
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levels. In fact extrusion also requires the application of large forces on the materials. On 
the other hand, inulin (HP) and skim milk were included in the formulations (Table 2.1) 
providing some cushing effect to the cells under stress together with the prebiotic 
activity. The technology of extrusion and spheronisation is complex and a good product 
is obtained when a combination of several factors is reached, namely plasticity of the wet 
masses, amount of granulation fluid and proper parameterisation of both extruder and 
spheroniser (Fielden et al., 1993). Due to the high pressure applied to the material, shear 
and frictional forces are present in the process. Furthermore the process is very sensitive 
to the amount of water present in the wet mass. In this work the amount of water is also 
of paramount importance for the preservation of bacterial viability, as discussed before. 
The observed viability decline could due to the combined effect of the forces applied 
(also present in tabletting) with the continuous decrease of the water content observed in 
the production of the pellets, which could have subjected the bacterial cells to osmotic 
shock (Mille et al., 2004), the severity of which determined the bacterial viability. Some 
authors (Huyghebaert et al., 2005a) reported a high sensitivity of L. lactis to pelletisation: 
they observed a 2 log units decrease in the survival rate of L. lactis due to extrusion-
spheronisation and fluid bed drying processes, 2 log units more in 1 week storage at 10% 
RH and complete viability loss in 1 week at 60% RH.  
Probiotic bacteria are commonly required to exert their action in the far small 
intestine or in the colon. Coating of active cores is an often-used strategy to reach this 
aim. Coating was observed to be substantially less deleterious relative to the viability of 
microorganisms compared to tablets and pellets. Taking into consideration the viability of 
LGG and L. bulgaricus, the small reduction of the viability can be explained by a series 
of reasons. The cores (both pellets and mini-tablets) showed a low water content, i.e., 
they were coated as dry cores and thus, no change on the water content was observed, 
except at their surface, where the application of the coating suspension did not promote 
the presence of high amounts of water at the surface of the cores, thus, the latter were not 
wetted. The initial viability decrease during coating was probably due to the loss of 
viability of cells present on the surface of the pellets and mini-tablets. Possible 
interference of bacteria with Eudragit FS30D affecting their viability cannot be ruled out. 
Furthermore the coat promoted a barrier to the environment. Although the coat was not 
 70
completely impermeable it probably prevented the oxygen (and moisture) to enter into 
contact with the bacteria, thus anaerobic conditions were promoted. Consequently, it was 
not surprising that further significant decrease of viable bacteria was not observed due to 
coating. 
 
2.5 Conclusions 
The work has identified the possibility of producing solid dosage forms containing 
viable bacteria as active moieties. The dosage forms considered reflect the most 
important ones administered by oral route. The work has also shown how, by different 
formulation and processing designs (powder, pellets, tablets and coated pellets and 
tablets), one can promote the release of bacteria in different segments of the digestive 
tract (stomach, small intestine or colon) according to the desired objective and function. 
The different bacteria chosen (3 vegetative forms and 1 spore form of prebiotic) have 
shown different viabilities to formulation and processing with decreasing viability as 
follows: B. subtilis (spores), L. plantarum, LGG and L. bulgaricus (vegetative forms). 
The most important factor to be considered in processing bacteria is the hydration 
state of the cells. The process of de-hydration is critical for obtaining a high survival rate. 
Freeze-drying has allowed high viability (less than 1 order of magnitude decrease) 
whereas drying observed throughout the process of extrusion and spheronisation has a 
high effect on the viability of bacteria. Also important is the fact that nutrients (skim 
milk, glycerol or mannose) and cryoprotectors should be present at early stages of 
processing (before de-hydration) to promote the stabilisation of bacteria. 
Tabletting was possible once compression aids (e.g. microcrystalline cellulose) were 
present to overcome the flow ability, stickiness and compaction problems of the freeze-
dried powders. However, microcrystalline cellulose presented a deleterious effect on the 
viability of bacteria. Here the compaction force seems to affect little the viability of the 
bacteria, particularly when direct compression of the materials was possible, due to the 
absence of changes on the residual water content of the materials. 
Pellets with intended characteristics were obtained from mixtures containing 
microcrystalline cellulose and lactose. The fact that bacteria were present in a suspension 
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(not in the dry state) and the process of extrusion and spheronisation promotes a 
continuous and slow drying of materials, both affected the viability of the bacteria 
throughout the process. 
Finally coating of either mini-tablets or pellets did not show major problems. The 
viability of the bacteria did not decrease further due to coating. 
To assure a high viability after storage both the temperature and relative humidity 
must be kept low. 
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CHAPTER 3 
 
PRESERVATION OF THE VIABILITY AND ANTIBACTERIAL 
ACTIVITY OF LACTOBACILLUS SPP. IN CALCIUM 
ALGINATE BEADS 
 73
 
3.1 Introduction 
Recently, the problems associated to the spread of antibiotic resistances among 
bacteria has led to a new interest in bacteriotherapy, a practice that makes use of 
commensal bacteria or beneficial bacteria to prevent or treat colonization of the host by 
pathogens (Peral et al., 2009; Huang et al., 2009; Skovbjerg et al., 2009). This approach 
is based on the competitive exclusion principle where the harmless commensal or 
probiotic bacteria (e.g. lactobacilli) successfully compete with potential pathogens for the 
same site (Huovinen, 2001; Reid et al., 2001) (see 1.1.2).    
However, to produce therapeutic benefits, sufficient number of viable and 
biologically active lactobacilli must be present. Consequently, finding optimal 
technological conditions to keep the organisms alive and active during processing and 
storage is a critical problem. Immobilization technology (e.g. entrapment of lactobacilli 
in alginate matrix) can be used as approach for stabilization, aiming to retain high density 
of active lactobacilli cells and protect them from hostile environments (see 1.2.7). 
 
3.2 Materials and Methods 
3.2.1 Materials 
Glycerol, sodium chloride and calcium chloride (Sigma-Aldrich, Chemie, Germany), 
disodium hydrogen phosphate and potassium di-hydrogen phosphate (Pancreac, 
Barcelona, Spain), ethylenediaminetetraacetic acid (EDTA, Merck, Darmstadt, 
Germany), sodium alginate (Protanal LF 10/60, FMC BioPolymer, Drammen, Norway) 
and skim milk (Difco, Detroit, USA) were used. The bacterial growth media used were de 
Man-Rogosa-Sharpe agar and broth (MRS), Mueller-Hinton (MH), Slanetz agar, 
Cetrimide agar and Drigalski lactose agar (Biokar Diagnostics, France) and CM 0085 
mannitol salt agar (Chapman), (Oxoid Ltd., England). 
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3.2.2 Methods 
3.2.2.1 Bacterial strains and culture conditions 
The lactobacilli strains examined, Lactobacillus plantarum ATCC 8014, 
Lactobacillus rhamnosus strain GG ATCC 53103 (LGG), Lactobacillus delbrueckii 
subsp. bulgaricus CIP 101027 and Lactobacillus delbrueckii subsp. lactis CIP 53.61, 
were grown overnight at 37ºC on MRS agar and in broth.  
The multi-resistant clinical isolates were cultivated overnight at 37ºC on selective 
agar media: a methicillin-resistant Staphylococcus aureus FFUL 29593 (Gaspar-Marques 
et al., 2006) was grown on Chapman; a vancomycine-resistant Enterococcus faecalis 
FFUL H164 (Gaspar-Marques et al., 2006) on Slanetz; a VIM-2-metalo-β-lactamase-
producing Pseudomonas aeruginosa  FFUL 1396, on Cetrimide and CTX-M-15-β-
lactamase producing strains: Escherichia coli FFUL 125269 (Brizio et al., 2006) and 
Klebsiella pneumoniae FFUL 193K (Conceiçao et al., 2005) on Drigalski.  
All stock cultures were maintained at -80ºC in growth medium supplemented with 
15% glycerol, except L. lactis, which was supplemented with 50% glycerol. 
 
3.2.2.2 Preparation of bacterial inocula  
The lactobacilli were used as whole cultures, culture filtrates and washed cells, as 
follows: Preparation of whole cultures - Whole cultures were the overnight broth cultures 
produced at 37ºC; Preparation of culture filtrates - Culture filtrates were obtained by 
centrifugation of the whole cultures (at 4000rpm for 20min at 4ºC) and filtration of the 
supernatants through cellulose acetate membrane filters (pore size 0.2µm); Preparation of 
washed cells - The cells harvested by centrifugation of the whole cultures were washed 
twice and resuspended to initial volume in physiological saline.  
An inoculum of each multi-resistant strain was prepared by suspending single 
colonies, from the overnight agar cultures, in physiological saline to result in an optical 
density equal to 0,5 McFarland that corresponded to approximately 1 x 108cfu/ml (colony 
forming units per ml). 
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3.2.2.3 Co-culture experiments 
Well diffusion method: The antibacterial activity spectra of the lactobacilli strains 
were determined by well diffusion method using the five multi-resistant clinical isolates 
as indicator strains. The assay was performed by using lactobacilli whole cultures, culture 
filtrates and washed cells. Aliquots (60µl) of each Lactobacillus inoculum were placed in 
wells (6-mm diameter) punched in cooled agar plates, which were previously inoculated 
with the multi-resistant strains by sterile cotton swabs.  Two types of agar media were 
considered. Mueller-Hinton (MH) was used as the medium of choice for susceptibility 
testing of commonly isolated, rapidly growing aerobic or facultative organisms (NCCLS, 
2003). However, lactobacilli are extremely fastidious organisms, requiring not only 
carbohydrates as energy and carbon source, but also nucleotides, aminoacids and 
vitamins (Kandler and Weiss, 1986). Therefore, MRS, being a specific lactobacilli 
growth medium, was also considered in the assay to test its effect on lactobacilli 
antibacterial activity. The plates were incubated overnight at 37ºC. The sizes of the 
inhibition zones (mm) were measured. 
Microdilution broth method: A microdilution broth method was carried out to study 
the relationship between the antibacterial activity and viability of lactobacilli cultures. 
The test was performed in 96-well microplates, as follows: Tenfold serial dilutions of the 
lactobacilli overnight cultures were prepared in physiological saline and in MRS broth 
(from 109 to 102cfu/ml). 90µl of each dilution were added to the wells containing 100µl 
of MH broth. When physiological saline was used in the serial dilutions, the MH broth in 
the wells was double concentrated in order to obtain its standard concentration after the 
addition of the lactobacilli and multi-resistant strains suspensions (NCCLS, 2003). The 
inocula of the multi-resistant strains were diluted 1/10 in physiological saline, so that the 
addition of 10µl to the wells would result in a concentration of 5 x 105cfu/ml. Positive 
control wells contained only the microdilution media and inoculum of each multi-
resistant strain. The microplates were incubated overnight at 37ºC. A droplet of each 
overnight culture from the microdilution wells was transferred to the selective agar media 
of the multi-resistant strains. The plates were also incubated overnight at 37ºC. The 
antibacterial activity of lactobacilli was determined as the lowest cell concentration of a 
Lactobacillus strain that completely inhibited the growth of a multi-resistant strain. 
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3.2.2.4 Preparation and characterisation of lactobacilli loaded calcium 
alginate beads 
3.2.2.4.1 Preparation of lactobacilli loaded calcium alginate beads 
Four types of lactobacilli loaded alginate beads were compared: 1) beads containing 
entrapped, 2) entrapped and surface, 3) surface and 4) concentrated entrapped and surface 
lactobacilli cultures. 
Beads containing entrapped lactobacilli (E beads): The encapsulation of lactobacilli 
overnight cultures in calcium alginate was a modification of the method described by 
Klinkenberg et al., 2001. Briefly, sodium alginate (1g) was autoclaved and dissolved in 
the overnight cultures (50ml) of each Lactobacillus strain by stirring at 50 rpm. Each cell-
alginate mixture was then added dropwise into a sterile solution of sodium chloride 
(0.2M) and calcium chloride (0.05M) through pipette tips with an inner diameter of 
0.5mm. Sodium chloride was used in the gelling solution to ensure a homogeneous 
polysaccharide concentration throughout the beads. To obtain complete gelling, the 
resulting 3.5mm beads were stirred at least 40 min at 50 rpm in this suspension prior to 
separation from the system by filtration under vacuum. The entire immobilization 
procedure was performed at room temperature.  
Beads containing entrapped and surface lactobacilli (ES beads): Lactobacilli loaded 
calcium alginate beads (50g) obtained as described above, were incubated in MRS broth 
at 37ºC for proliferation of the lactobacilli to the beads surfaces (Prevost et al., 1985). 
Incubation of the beads was ceased in 4.0h (L. plantarum), 4.5h (LGG) and 6.0h (L. 
bulgaricus and L. lactis) when the concentration of free lactobacilli cells corresponded to 
107cfu/ml for L. plantarum, LGG and L. lactis and 106cfu/ml for L. bulgaricus.  
Beads containing surface lactobacilli (S beads): Blank alginate beads, containing no 
lactobacilli but only MRS broth, were incubated for 16h at 37ºC in MRS broth inoculated 
with 100µl of L. plantarum overnight culture. 
Beads containing concentrated entrapped and surface lactobacilli cell suspensions 
(CES beads): Two different approaches, 1) centrifugation and 2) repeated fermentations, 
were compared in concentrating L. plantarum suspensions immobilized in alginate beads. 
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 1) L. plantarum overnight cultures were centrifuged (4000 rpm for 30min at 4ºC) and 
the cells were resuspended in tenfold smaller volume of the supernatant.  
2) The effect of two types of media, MRS broth supplemented with 1% CaCl2 and 
reconstituted skim milk (10%), on concentrating immobilized L. plantarum cultures was 
studied. L. plantarum alginate beads (50g) were three times subsequently incubated in 
either medium for 4h at 37ºC. Afterwards L. plantarum beads fermented in MRS broth 
with CaCl2 were incubated in MRS broth for 4h at 37ºC, while the beads fermented in 
skim milk were incubated for halftime at the same conditions. 
Blank calcium alginate beads (BC), containing only MRS broth, were used as 
controls. 
 
All types of beads were frozen at -80ºC for 24h and dried under vacuum at room 
temperature, 0.035mbar for 24h (Christ Alpha 1-4, B. Braun Biotech International, 
Germany). The beads produced were kept over silica gel, at 4ºC, for a period of 6 months. 
These beads were considered for further characterisation. Scanning electron microscopy, 
determination of calcium content, physical properties and release of lactobacilli from 
beads were performed only with L. plantarum loaded beads because S- and CES -beads 
were prepared only with L. plantarum. 
 
3.2.2.4.2 Scanning electron microscopy 
Samples from the beads were mounted on metal stubs with double sided adhesive 
tape, coated with gold using fine coater (JEOL JSM-1200, Japan) under vacuum and 
15mA at room temperature. The morphology of coated samples was examined by 
scanning electron microscopy (SEM; JEOL JSM-5200 LV, Japan). 
 
3.2.2.4.3 Calcium content 
The calcium content in the prepared beads was measured by atomic absorption 
analysis (Perkin Elmer AAnalyst – 700). A series of standard calcium solutions (0; 1; 2; 
4; 6; 8 and 10mg/l) was prepared from: 0, 0.5, 1, 2, 3, 4 and 5ml calcium stock solution 
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(100mg/l), 10ml EDTA solution (37.7g/l) and deionised water up to 50ml. Samples 
(100mg) from beads were dissolved in sodium citrate solution (1%, pH 6.0) and then 
diluted in EDTA solution (7.5g/l) and deionised water. The calcium content in the 
samples was determined by comparison with the standard solutions in the calibration 
curve. 
 
3.2.2.4.4 Physical properties 
The major and minor axes of beads were measured using an upright microscope 
Olympus CX40, Japan, equipped with an Olympus Colour View IIIu Camera and Cell D 
2006 Olympus Software. Bead shape was characterized by aspect ratio, defined as the 
ratio between the major and the minor bead axis. The closer the values of the aspect ratio 
were to 1, the more spherical the bead was.  
The force required to crush the calcium alginate beads was measured. The beads were 
placed between two horizontal plates, perpendicular to their movement and crushed 
(CT5, Engineering System, Nottm, UK).  
 
3.2.2.4.5 Release of lactobacilli 
Beads (100mg) were placed into tubes containing 10ml of phosphate buffered saline 
(PBS) (pH 7.4) and then placed into a shaking water bath at 37ºC (20 osc/min). PBS was 
prepared by mixing of 1 ml of phosphate buffer (pH 7.5; 0.33M) with 29ml of sodium 
chloride (9g/l). At specified time periods (10, 30, 60, 120, 270, 360 and 600 minutes), 
100µl from every test tube were withdrawn and replaced with fresh PBS. Serial dilutions 
were made in sterile water and plated in duplicate on MRS agar to allow counting of 
lactobacilli released. The percentage of bacteria released was calculated from the initial 
viable count of lactobacilli per gram of beads. 
 
3.2.2.4.6 Viability of lactobacilli  
The lactobacilli viability was determined before and after immobilisation and freeze-
drying and during six months of storage (4ºC over silica gel) by the agar plate method. 
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Calcium alginate was dissolved in sterile sodium citrate solution (1%, pH 6.0) followed 
by serial dilutions made in sterile water and plated in duplicate on MRS agar. 
  
3.2.2.4.7 Antibacterial activity 
Well diffusion method: The antibacterial activity of the immobilized into beads 
lactobacilli cultures was initially tested by the well diffusion method as described above. 
Instead of lactobacilli inocula, alginate beads containing 107 to 108 entrapped lactobacilli 
cells were used. Macrodilution broth method: The applied macrodilution broth method 
reproduced the conditions of the performed microdilution broth test. It was used to test 
the antibacterial activity of lactobacilli after processing into beads and during 6 months of 
storage.  
 
3.3 Results 
3.3.1 Antibacterial activity of lactobacilli before processing 
3.3.1.1 Well diffusion method 
 Well diffusion method was applied in a comparative study of the antibacterial activity 
of the lactobacilli whole cultures, culture filtrates and washed cells against the multi-
resistant clinical isolates (Table 3.1). The antibacterial activity of lactobacilli against S. 
aureus and E. faecalis was compared on both MH and MRS agar, while against P. 
aeruginosa, E. coli and K. pneumoniae on MH agar only, as the latter microorganisms 
did not grow on MRS agar. 
When whole cultures were used, all lactobacilli strains showed antibacterial activity 
against all Gram-positive and Gram-negative multi-resistant isolates, while the culture 
filtrates of lactobacilli were only active against the Gram-negative strains and S. aureus 
on MH agar. Although all lactobacilli strains, except L. bulgaricus, were able to grow on 
MH agar, the activity of L. plantarum, LGG and L. bulgaricus washed cells was observed 
only on MRS agar. Only L. lactis washed cells inhibited S. aureus on both media (Table 
3.1). The sizes of the inhibition zones on MH agar were ranging from 8 to 16mm, while 
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on MRS from 13 to 30mm. L. bulgaricus produced the smallest inhibition zones on MH 
agar (from 8 to 10mm). 
The antibacterial activity of lactobacilli against S. aureus was observed when the 
whole cultures were applied on both MRS and MH agar and the washed cells on MRS 
agar. The culture filtrates were active only on MH agar. However, for E. faecalis the 
lactobacilli activity was only observed when the whole cultures or washed cells were 
used on MRS agar, by contrast to the non-active culture filtrates. Furthermore, similar 
inhibition zones were caused by either whole cultures or washed cells (mean values of 17 
and 16mm, respectively). Both whole cultures and culture filtrates of lactobacilli 
inhibited P. aeruginosa, E. coli and K. pneumoniae, producing similar inhibition zones 
(mean value of 12mm). 
All further experiments were performed with whole lactobacilli cultures only, as they 
have shown the widest antibacterial spectrum. 
 
Table 3.1 Antibacterial activity of the whole cultures, culture filtrates and washed cells of the 
lactobacilli strains represented by the size of the inhibition zones (mm). 
P. aeruginosa E. coli K. pneumoniae
MRS MH MRS MH MH MH MH
L. plantarum 22 12 18 ni 12 12 12
LGG 22 11 18 ni 12 12 11
L. bulgaricus 20 8 14 ni 10 10 9
L. lactis 28 16 18 ni 13 14 12
P. aeruginosa E. coli K. pneumoniae
MRS MH MRS MH MH MH MH
L. plantarum ni 10 ni ni 13 14 10
LGG ni 11 ni ni 12 13 10
L. bulgaricus ni ni ni ni 9 10 ni
L. lactis ni 9 ni ni 13 14 9
P. aeruginosa E. coli K. pneumoniae
MRS MH MRS MH MH MH MH
L. plantarum 14 ni 18 ni ni ni ni
LGG 14 ni 18 ni ni ni ni
L. bulgaricus 14 ni 13 ni ni ni ni
L. lactis 30 14 14 ni ni ni ni
Washed cells
S. aureus E. faecalis
Whole cultures
S. aureus E. faecalis
Culture filtrates
S. aureus E. faecalis
 
ni = no inhibition; MRS = de Man-Rogosa-Sharpe agar; MH = Mueller-Hinton agar 
 
3.3.1.2 Microdilution broth method  
The microdilution broth method was used to represent the antibacterial activity of 
lactobacilli cultures as a function of lactobacilli viability (Figure 3.1). When the medium 
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in the wells comprised MH, appropriate medium for the growth of the multi-resistant 
strains, the lactobacilli were active at high cell densities, i.e. 107 to 108cfu/ml. When 
MRS was added to the microdilution medium in order to facilitate the development of 
lactobacilli, the number of lactobacilli necessary to inhibit the multi-resistant strains was 
lower by 1 to 2 log units (105-107cfu/ml) against S. aureus, E. faecalis, E. coli and K. 
pneumoniae and by 4 log units (103cfu/ml) against P. aeruginosa (Figure 3.1). Positive 
controls showed that both microdilution media (MH and MH+MRS) yielded satisfactory 
growth of the multi-resistant strains (108 to 109cfu/ml). 
 
 
Figure 3.1 Antibacterial activity of lactobacilli determined by microdilution broth method in (■): 
MH+physiological saline and (■): MH+MRS against S. aureus (Sa), E. faecalis (Ef), P. aeruginosa (Pa), E. 
coli (Ec) and K. pneumoniae (Kp), represented as the logarithm of the minimal number of lactobacilli cells 
necessary to inhibit completely the growth of the multi-resistant strains. 
 
3.3.2 Lactobacilli loaded calcium alginate beads 
3.3.2.1 Physical characteristics 
According to the physical characteristics two groups of beads could be distinguished 
(Table 3.2). The first group, represented by BC and E beads had a spindle shape, 
resembling prolate ellipsoids. They were characterized by smaller weight, higher calcium 
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content and higher force at crush. The second group, represented by ES and CES beads, 
resembled more spherical ellipsoids. These beads had bigger weight and lower calcium 
content and force at crush. Interestingly, S beads showed characteristics from both 
groups. S beads had spindle shape and smaller weight like BC and E beads, whereas their 
calcium content was more similar to the group of ES and CES beads, although their force 
at crush was in-between both groups. 
 
Table 3.2 Physical characteristics of calcium alginate beads 
Calcium Content Weight Crushing Force
[mM] [mg] [N]
BC 1.51 2.06±0.76 0.93±0.25 1.48±1.22
E 1.55 1.67±052 093±009 1.73±1.49
ES 0.47 1.4±0.40 1.82±0.35 1.02±1.62
S 0.65 1.67±0.56 1.01±0.19 1.19±0.58
CES 0.58 1.28±0.23 2.00±0.41 1.06±0.60
Beads Aspect ratio
 
BC (blank control beads), E (beads containing entrapped lactobacilli); 
ES (beads containing both entrapped and surface lactobacilli); 
S (beads containing surface lactobacilli); 
CES (beads containing concentrated entrapped and surface lactobacilli). 
 
The morphology of the two groups was also distinct (Figure 3.2, a-e). The internal 
and external surfaces of BC and E beads were rough, while the ones of ES, CES and S 
beads were smooth. Large colonization on the entire surface was observed particularly in 
CES beads, followed by ES beads. Rare lactobacilli gathered in groups were found only on 
the external surfaces of S beads. 
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Figure 3.2 Scanning electron photomicrographs of the external surface of a) blank bead (BC); b) bead 
containing entrapped lactobacilli (E); c) bead containing entrapped and surface lactobacilli (ES); d) bead 
containing concentrated entrapped and surface lactobacilli (CES); e) bead containing surface lactobacilli (S). 
a) 
c) d) 
b) 
e) 
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3.3.2.2 Release characteristics 
Release of the total quantity of lactobacilli was observed in the first 10 min from S 
beads (Figure 3.3).  The released lactobacilli in the first 10 min from the other types of 
beads corresponded to 1.4% or 109cfu/g for CES beads; 2.1% or 107cfu/g for E beads; and 
2.5% or 108cfu/g for ES beads (Figure 3.3). ES, E and CES beads released their total 
quantity of lactobacilli as follows: up to the second, forth and tenth hour, respectively. 
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Figure 3.3 Release of lactobacilli from beads, represented as log cfu/g (a) and in % (b), (beads 
containing ♦ entrapped (E), ■ entrapped and surface (ES), ▲ surface (S); ○ concentrated entrapped and 
surface lactobacilli (CES)). 
a) 
b) 
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3.3.2.3 Viability and antibacterial activity 
Tests of the antibacterial activity of beads containing entrapped lactobacilli (E beads) 
were performed on agar plates by well diffusion method. Immediately after 
immobilization L. plantarum, LGG and L. bulgaricus loaded beads demonstrated 
decreased (i.e. smaller inhibition zones) or no antibacterial activity. However, 
immobilisation did not influence the antibacterial activity of L. lactis (data not shown). 
Freeze-drying of E beads led to low survival rates of L. bulgaricus (from 2.3 x 108 to 1.5 
x 106cfu/ml) and L. lactis (1.0 x 109 to <102 cfu/ml) (Figure 3.4a) and lack of inhibitory 
activity. 
Incubation of E beads in MRS broth led to proliferation of lactobacilli to the surface 
of the beads and surface colonization (ES beads) (Figure 3.2c). ES beads showed a better 
survivability of lactobacilli, particularly of L. bulgaricus and L. lactis, during freeze-
drying compared to E beads (Figure 3.4). The viability decrease of lactobacilli in ES 
beads due to freeze-drying was ≤ 1 log unit (from 3.4 x 109 to 3.5 x 108cfu/ml for L. 
plantarum, from 1.1 x 109 to 4.9 x 108cfu/ml for LGG, from 1.7 x 108 to 1.8 x 107cfu/ml 
for L. bulgaricus and from 1.0 x 109 to 5.2 x 108cfu/ml for L. lactis) (Figure 3.4b). 
Preserved antibacterial activity of ES beads was first observed on agar and then 
confirmed in broth. Figure 3.5 represents the antibacterial activity of ES beads as a 
function of lactobacilli viability and compares it to the antibacterial activity of lactobacilli 
cultures before processing. The antibacterial activity of L. lactis against S. aureus, P. 
aeruginosa and K. pneumoniae in MH broth remained unchanged after processing and 
inhibition was obtained by 107 L. lactis cells. Processing influenced little the antibacterial 
activity of L. plantarum and LGG against E. coli and K. pneumoniae in MH broth and 
inhibition was obtained by 108 lactobacilli cells. A change in activity after processing of 
L. lactis against E. coli and of L. plantarum and LGG against S. aureus, E. faecalis and P. 
aeruginosa was reflected by 1 log unit increase (from 107 to 108cfu/ml) of the lactobacilli 
cells necessary to inhibit the multi-resistant strains. More pronounced change in activity 
was marked only when L. lactis beads were used against E. faecalis. Inhibition was 
observed by 109 immobilized L. lactis cells versus 107 non-processed L. lactis cells. 
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Figure 3.4 Alginate beads, containing a) entrapped (E) and b) entrapped and surface lactobacilli (ES). 
Number of viable lactobacilli (mean and SD, n=3) in overnight cultures (black bar), wet alginate beads 
(dashed bar) and dry alginate beads (grey bar). 
 
By analogy with the overnight cultures, the antibacterial activity of the immobilized 
lactobacilli against S. aureus and K. pneumoniae was promoted by MRS broth, reflected 
by 1 to 2 log units reduction of the lactobacilli cells necessary to obtain inhibition (from 
107-108 in MH broth to 106-107cfu/ml in MH+MRS broth). The influence of MRS was 
again most significant against P. aeruginosa decreasing 3 to 4 log units the number of 
lactobacilli cells necessary to inhibit the organism (from 108 to 104cfu/ml for L. 
a) 
b) 
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plantarum; from 108 to 105cfu/ml for LGG; from 107 to 104cfu/ml for L. lactis) (Figure 
3.5). Independent of the broth medium the immobilized lactobacilli were only active 
against E. coli and E. faecalis incubated at high cell densities, i.e. 108 and 109cfu/ml, 
respectively. The antibacterial activity of the immobilized LGG and L. lactis against E. 
faecalis could not be determined late in storage (Figure 3.5), which could be related to a 
71% viability decrease, i.e. from 9.0 x 109 cfu/g after freeze-drying to 2.5 x 109 cfu/g 
(Figure 3.6a). Similarly, the antibacterial activity of L. bulgaricus against all multi-
resistant strains, except P. aeruginosa in the combined medium of MH with MRS, could 
not be determined. Lactobacilli viability in ES beads decreased ≤ 1 log unit until the end 
of storage (from 9.0 x 109 to 3.7 x 109cfu/g for L. plantarum; 8.5 x 109 to 2.5 x 109cfu/g 
for LGG; 9.0 x 109 to 2.5 x 109cfu/g for L. lactis; 1.8 x 108 to 1.9 x 107cfu/g L. 
bulgaricus) (Figure 3.6a). 
The alginate beads containing surface lactobacilli only (S beads), reached cell 
concentrations of 108cfu/ml at the end of incubation. However, their viability dropped 2 
log units (106cfu/ml) during freeze-drying, which was not sufficient to be inhibitory 
active. 
 
 Figure 3.5 Antibacterial activity of lactobacilli (mean and SD, n=3) in beads containing entrapped and surface lactobacilli (ES beads), represented as the 
logarithm of the minimal number of lactobacilli colony forming units (cfu) necessary to inhibit completely the growth of the multi-resistant strains determined 
during six months of storage at 4ºC, with the overnight cultures (OC) as controls. (■): MH; (■): MH+MRS. 
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Figure 3.6 Viability of lactobacilli (mean and SD, n=3) in different conditions 
a) lactobacilli in dry alginate ES beads throughout 6 months of storage at 4ºC for L. plantarum (●), 
LGG (■), L. bulgaricus (▲) and L. lactis (○); 
b) L. plantarum in alginate beads during four repeated fermentations: three in skim milk  
(-) and in MRS broth with 1% CaCl2 (■) and a final fermentation in MRS broth (○); 
c) L. plantarum in non-concentrated and concentrated beads before (■) and after freeze-drying (■). 
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The observed relationship between antibacterial activity and viability suggested that 
concentrating the immobilized cells could be an approach for optimization. CaCl2 was 
added to MRS to improve the beads stability (Morin et al., 1992), evading softening or 
dissolution of the beads during repeated fermentations. Fermentations performed in MRS 
broth supplemented with 1% CaCl2 led to an increase of L. plantarum cell concentrations 
(5 x 109 to 2 x 1010cfu/ml), while in skim milk the number of cells remained unchanged 
(Figure 3.6b). Concentrating L. plantarum immobilized suspensions made the 
microorganism more resistant to freeze-drying (from 2 x 1010cfu/ml before freeze-drying 
to 1.2 x 1010cfu/ml or 2.2 x 1011cfu/g after freeze-drying for beads concentrated by 
fermentation in MRS with CaCl2; from 1.5 x 1010cfu/ml to 7 x 109cfu/ml (1.4 x 1010cfu/g) 
for beads concentrated by centrifugation) (Figure 3.6c). When the antibacterial activity of 
the concentrated beads was tested in MH+MRS, the concentration of L. plantarum in 
beads was reflected by a decrease (about 1/10) of the number of beads required to reach 
inhibition. However, in MH medium the relationship between the antibacterial activity 
and the viability of the concentrated beads was different from non-concentrated beads 
(Figure 3.7), i.e. the concentrated beads needed more cells to inhibit the multi-resistant 
clinical isolates in MH broth. Consequently, the process of concentration was not 
reflected by a decrease of the number of beads required to reach inhibition. 
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Figure 3.7 Antibacterial activity (mean and SD, n=3) of L. plantarum non-concentrated ES beads 
(black bar), fermented in skim milk (dashed black bar), fermented in MRS broth with 1% CaCl2 (grey bar) 
and concentrated by centrifugation beads (dashed grey bar), represented as logarithm of the minimal 
number of colony forming units (cfu) of L. plantarum necessary to inhibit completely the growth of the 
multi-resistant strains, determined in MH broth. 
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3.4 Discussion 
3.4.1 Antibacterial activity of lactobacilli before processing 
According to the results of the well diffusion method the whole lactobacilli cultures 
had the widest antibacterial spectrum compared to culture filtrates and washed cells. It 
was due to the fact that lactobacilli antibacterial activity against the Gram–positive multi-
resistant strains was cell related, while against the Gram-negative strains referred to 
antibacterial substances excreted in the culture filtrates. 
The observation that lactobacilli culture filtrates were active against S. aureus only on 
MH agar, suggested that the activity of lactobacilli whole cultures and washed cells on 
MRS agar against the organism could not be due to the antibacterial substances excreted 
into the broth, but could be mediated by production of antibacterial substances during the 
co-growth of the antagonistic strains on MRS agar. Similar interpretation could be made 
concerning lactobacilli activity against E. faecalis. The fact that lactobacilli cells were 
necessary for the inhibition of E. faecalis and inhibition occurred on MRS agar only 
suggested that the antibacterial activity against E. faecalis could be related to antibacterial 
substances produced during the growth of lactobacilli on MRS agar and not in MRS 
broth. Further proof of this suggestion was obtained by the similar sizes of the inhibition 
zones produced by either whole cultures or washed cells. Strains exhibiting antagonistic 
effects only on agar but not in liquid medium have been described in literature 
(Schillinger and Lücke, 1989).  
The antibacterial activity against the Gram-negative multi-resistant isolates could be 
mediated by antibacterial substances excreted during the growth of lactobacilli in MRS 
broth. The results were in accordance to the conclusions reached by Valdez et al., 2005, 
who observed inhibition of P. aeruginosa PA100 by whole cultures and culture filtrates 
of L. plantarum ATCC10241. Moreover, these researchers showed that L. plantarum 
ATCC10241 can inhibit the production of P. aeruginosa quorum-sensing signal 
molecules and the virulence factors elastase and biofilm formation controlled by these 
signal molecules. 
The fact that lactobacilli washed cells were active on MRS agar and not on MH 
suggested that, although MH permitted the growth of lactobacilli it did not promote their 
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antibacterial activity. This observation was confirmed by the sizes of the inhibition zones. 
The sizes of the inhibition zones on MH agar produced by whole cultures (mean value of 
12mm) were corresponding to the sizes of the inhibition zones produced by the culture 
filtrates (mean value of 12mm), while the inhibition zones of the whole cultures on MRS 
agar were larger (mean value of 20mm). 
A relationship between lactobacilli antibacterial activity and viability has been found 
by the microdilution test. A density of 107-108 cells/ml was necessary to observe 
inhibition in MH broth. Promotion of the lactobacilli antibacterial activity against the 
multi-resistant strains, most significant against P. aeruginosa, was observed in the 
presence of MRS in the microdilution medium (Figure 3.1). This phenomenon could be 
due to enhanced production of highly active bacteriocins by MRS medium. In a different 
study (Todorov and Dicks, 2005), despite of the relatively good cell growth, low 
bacteriocin activity ranging from 200 to 800 AU/ml (AU=arbitrary units) was recorded as 
a result of growing L. plantarum ST23LD in M17 broth, BHI broth and soy milk. L. 
plantarum ST23LD produced the highest activity of its bacteriocin (25600 AU/ml) when 
grown in MRS broth.  
 
3.4.2 Lactobacilli loaded calcium alginate beads  
The observed antibacterial activity of the lactobacilli strains against multi-resistant 
strains allowed us to consider the development of a formulation containing overnight 
lactobacilli cultures with preserved and stable viability and antibacterial activity. The 
composition of the formulation had to be poor, containing no nutrients which could boost 
the growth of the multi-resistant strains and on the other hand it had to protect the 
lactobacilli cells during processing and preserve their antibacterial activity. Following the 
previous discussion, the presence of MRS could be favourable in a formulation 
containing lactobacilli. 
When the cell-alginate suspension was added to CaCl2 solutions, calcium alginate 
beads were formed. However, alginate beads are not inert but are constantly in interaction 
with the medium in which they are put (Velings and Mestdach, 1995). Therefore, the 
morphology of the beads before and after incubation in MRS broth was quite different 
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(Figure 3.2: BC and E beads vs. ES, CES and S beads). It might be due to the interaction 
between the lactobacilli cells and the calcium alginate matrix. The rough internal and 
external surfaces of beads (BC and E beads) were transformed into smooth surfaces 
during the proliferation of lactobacilli in calcium alginate gel (ES, CES and S beads). The 
proliferation of lactobacilli resulted in a decrease of the calcium content in the beads 
(Table 3.2: BC and E beads vs. ES, CES and S beads), which could be due to production of 
lactic acid by the bacteria during incubation of beads in MRS broth, which competes with 
the alginate for calcium (Morin et al., 1992). The decrease in calcium in the calcium–
alginate network in ES, S and CES beads resulted in a destabilising effect reflected by 
lower forces at crush (Table 3.2). Lower calcium content is related also to network 
formation with increased space occupied by alginate and therefore increased bead volume 
and on the other hand to higher medium absorption into the beads (Velings and 
Mestdach, 1995). Higher MRS absorption into ES and CES beads might have contributed 
to obtain higher values of dry beads weight. However, this factor is probably of minor 
significance, as proven by S beads. Although S beads had lower calcium content, 
comparable to ES and CES beads, their weight was smaller, similar to BC and E beads. 
Other factors that might have resulted in increase of ES and particularly CES beads weight 
are the biomass increase (Trauth et al., 2001) and the accumulation of metabolic products 
in beads (Lacroix et al., 2005). Furthermore, S, E and BC beads shrank during freeze-
drying and their shape changed from spherical to prolate ellipsoid, while the shape of ES 
and CES beads remained more spherical. This fact suggests that the creation of networks 
between lactobacilli during their proliferation to beads surface could have helped 
avoiding bead shrinkage during freeze-drying and preserving bead shape. 
Several factors influenced lactobacilli release from beads. The presence of surface 
lactobacilli in alginate beads explained the observed burst effect: immediate release after 
contact with PBS of the total lactobacilli content from S beads, and of 1.4 to 2.5% from 
the other types of beads (Figure 3.3). The decreased crosslinking density with calcium 
and the consequent increase of porosity (Wan et al., 2008) and lower mechanical 
strength, reflected by lower forces at crush, could explain the quicker lactobacilli release 
from ES beads than from E beads (Figure 3.3). 
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The presence of both surface and entrapped lactobacilli was found to promote higher 
survival rates during freeze-drying. The survival rates were higher in ES and CES than in 
E and S beads (Figure 3.4a,b and 3.6c). In general, surviving fraction of the 
microorganisms during freeze-drying increases with the increasing biomass 
concentration, and this is attributed to the mutual shielding effect of the microorganisms 
against the severe conditions of the external medium (Bozoglu et al., 1987). In the present 
study, 109-1010cfu/ml was found to be optimal initial bacterial cell concentration resulting 
in the highest survivability during freeze-drying (ES and CES beads). On the other hand, 
108cfu/ml was found to be too low (S beads): the cell viability might be lowered through 
lack of the protective effects generated by mutual contact of the cells due to lack effective 
networks (Souzu, 2004). 
Immobilization of lactobacilli in calcium alginate to obtain beads containing 
entrapped lactobacilli (E beads) and subsequent freeze-drying led to partial or complete 
loss of lactobacilli antibacterial activity. As discussed, high lactobacilli viability was a 
prerequisite to observe antibacterial activity. On the other hand, possible reasons to 
explain the lack of activity when high viability was preserved (L. plantarum and LGG 
beads) could be due to a slow release of antibacterial substances or cells from the beads 
(George and Abraham, 2006), as well as, a change in activity of lactobacilli and their 
metabolic products due to process of desiccation (Viernstein et al., 2005). Incubation of 
beads in MRS broth to obtain ES beads contributed to preserve lactobacilli antibacterial 
activity. This could be due to 1) the better survivability of lactobacilli during freeze-
drying; 2) the presence of surface lactobacilli leading to burst effect of cells; and to 3) the 
decrease of calcium from the calcium-alginate network of the beads, which could have 
contributed to quicker release of not only cells (Figure 3.3) but also of antibacterial 
substances, important for the promotion of the antibacterial effects of the lactobacilli. On 
the other hand, beads containing surface lactobacilli (S beads) showed lower survival 
rates during freeze-drying and consequently no inhibition. Concentrated alginate beads 
(CES) did not have any advantage referring lactobacilli antibacterial activity compared to 
ES beads. A possible explanation could be that the increase of the number of lactobacilli 
cells in the concentrated beads could have not corresponded to an equivalent increase of 
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the antibacterial substances. Wan et al., 1995, found that in repeated batch fermentations, 
immobilized cells produced less bacteriocin than free cells. 
 
3.5 Conclusions  
The study has confirmed the possibility of immobilization of different lactobacilli 
strains in calcium alginate by transformation of cell cultures into solid beads. 
Nevertheless a decrease of antibacterial activity and viability due to immobilization and 
freeze-drying was observed, this decrease could be reversed with further incubation of the 
dosage forms in MRS medium. The consequent proliferation of the entrapped lactobacilli 
to the beads surface resulted in a significant change in the physicochemical properties of 
beads showing smoother surface morphology, more spherical shape, bigger weight, lower 
calcium content and force at crush. 
The study showed that lactobacilli cultures at high cell concentrations of 108cfu/ml 
had wide antibacterial spectrum against both Gram-positive and Gram-negative multi-
resistant clinical isolates. Furthermore, the preservation of lactobacilli antibacterial 
activity during processing and storage was related to the preservation of their viability.  
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CHAPTER 4 
 
ALGINATE FILMS CONTAINING LACTOBACILLUS 
PLANTARUM AS WOUND DRESSING FOR PREVENTION OF 
BURN INFECTION: PREPARATION, IN VITRO AND IN VIVO 
EVALUATION 
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4.1 Introduction 
The experience in topical bacteriotherapy in burn patients is limited (see 1.1.2.8). 
However promising results (Peral et al., 2009) suggest that lactobacilli could be a novel 
and useful approach for local prevention and treatment of burn wound infections.  
 
4.2 Materials and Methods 
4.2.1 Materials 
The used materials (glycerol, sodium chloride, calcium chloride, 
ethylenediaminetetraacetic acid, sodium alginate, de Man-Rogosa-Sharpe agar and broth 
(MRS), Mueller-Hinton (MH) and Cetrimide agar) were listed in 3.2.1. 
 
4.2.2 Methods 
4.2.2.1 Bacterial strains and culture conditions 
Lactobacillus plantarum ATCC 8014 was grown overnight at 37ºC on MRS agar and 
in broth. A VIM-2-metalo-β-lactamase-producing Pseudomonas aeruginosa FFUL 1396, 
isolated from abdominal wound of a patient at a Central Hospital of Lisbon, was grown 
overnight at 37ºC on its selective agar medium Cetrimide.  
P. aeruginosa was chosen as an indicator strain in this study based on its prevalency 
in burn patients, resulting in severe complications and mortality reaching up to 40-50% 
(Estahbanati et al., 2002). Treatment of P. aeruginosa infections is difficult due to the 
high frequency of P. aeruginosa resistance (Pournaras et al., 2009; Estahbanati et al., 
2002). 
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4.2.2.2 Preparation and in vitro evaluation of L. plantarum loaded calcium 
alginate films 
4.2.2.2.1 Preparation of L. plantarum loaded calcium alginate films 
Sodium alginate (1g) was dissolved in L. plantarum overnight cultures (50ml). 9.5ml 
of the cell-alginate suspension was poured into a Petri plate (5.5cm diameter) containing 
3ml of twofold increasing CaCl2 concentrations (0.05-12.8M). The films were cured for 
15h at 4ºC in the calcium solutions to reach steady state equilibrium (Velings and 
Mestdagh, 1995). Ellipse shaped films were obtained. The time of film formation was 
recorded and film dimensions were measured with Calliper. After curing each film was 
incubated in MRS broth at 37ºC/4h to obtain proliferation of the entrapped lactobacilli to 
the films surfaces. Blank films, containing only MRS broth and no lactobacilli, were used 
as controls. 
All types of films were frozen at -80ºC for 24h and dried under vacuum at room 
temperature, 0.035mbar for 24h (Christ Alpha 1-4, B. Braun Biotech International, 
Germany). The films produced were kept over silica gel, at 4ºC, for period of 6 months. 
These films were considered for further characterisation. 
 
4.2.2.2.2 Scanning electron microscopy 
The morphology of samples from the lactobacilli loaded and blank films was 
examined as described in 3.2.2.4.2. 
 
4.2.2.2.3 Calcium content 
The calcium concentration in the films is paramount to their formation and physico-
chemical properties; therefore the amount of calcium remaining in the film provides 
information of the properties of the films. It was determined according to 3.2.2.4.3. 
 
4.2.2.2.4 Water absorption capacity 
Film strips (dimensions 3.2 x 2.2 x 0.4 cm) were suspended in 50ml of phosphate-
buffered saline (PBS) (pH 7.4) at room temperature. At specified time intervals (ranging 
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between 1 minute and 48 hours, depending on the film), the films were taken out and the 
excess of water removed carefully with filter paper, then weighed immediately. The 
swelling ratio of the films was calculated as the ratio between the weight of a swollen 
sample to that of a dry sample. 
 
4.2.2.2.5 Mechanical properties 
The mechanical properties of film strips (3.2 x 2.2 x 0.4 cm) were measured using a 
texture analyzer (TA.XTPlus, Stable Micro Systems, UK) equipped with a 5 kgf (approx. 
50N) load cell and fit with a three-point bending rig apparatus. Film strips were hydrated 
for 5 minutes, to allow comparison between different films, and placed over the supports, 
positioned at a distance of 7 mm. The upper blade moved down equidistant from the two 
lower supports at a speed of 3 mm/s. The breaking force was measured and the tensile 
strength (Davies and Newton, 1995) and Young’s modulus (Rowe and Roberts, 1995) 
were calculated as follows:  
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where, σf is the tensile fracture stress, F is the load at fracture, l is the distance 
between the supports, b is the film width, d is the film depth, , E is Young’s modulus, ξ is 
the central deflection. 
 
4.2.2.2.6 Bioadhesion properties 
The bioadhesive strength of the films was evaluated according to Sezer et al. [17] 
(2007). The measurement was conducted with a texture analyzer (TA.XT Plus, Stable 
Micro Systems, UK) fit with a 5 kgf load cell and bioadhesion test apparatus which 
included a cylindrical Perspex probe. Chicken back skin was used as a model tissue, after 
the removal of all fats and debris. The dermal tissue was fitted on the bioadhesion test 
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apparatus, and then 100µl of demineralised water was applied on the surface of the tissue 
prior to measurements at 37ºC. The film was cut into small cylinders shape and attached 
to probe with double sided adhesive. The probe was lowered onto the surface of the tissue 
with a constant speed of 1mm/s and constant force of 1N applied. After keeping in 
contact for 30 seconds, the probe was then moved vertically upwards at a constant speed 
of 1mm/s. Work of adhesion (J/m2) and peak detachment force (N/m2) were calculated 
from the force versus displacement graphic. 
 
4.2.2.2.7 Release of lactobacilli 
The release of lactobacilli from films was studied as described in 3.2.2.4.5. 
 
4.2.2.2.8 Viability of lactobacilli  
The lactobacilli viability was determined before and after immobilisation and freeze-
drying and throughout 6 months of storage by the agar plate method. 20 mg samples were 
collected from the centre and the periphery of films. These results were averaged for each 
sample and then the mean and standard deviation calculated: low standard deviation 
reflected little variation between the centre and the periphery of the film. Calcium 
alginate was dissolved in sterile sodium citrate solution (1%, pH 6.0) followed by serial 
dilutions made in sterile water and plated in duplicate on MRS agar. 
  
4.2.2.2.9 Antibacterial activity 
Micro- and macrodilution broth methods (see 3.2.2.3 and 3.2.2.4.7) were used to test 
the in vitro antibacterial activity of L. plantarum before and after processing into calcium 
alginate films and during 6 months of storage. Samples were analyzed at 6th, 8th, 10th and 
24thh to determine the time necessary for the inhibition of P. aeruginosa. 
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4.2.2.3 In vivo experiments 
Studies were carried out using 25 male Wistar rats (from 292 to 384g, Harlan Ibérica, 
Barcelona, Spain). Rats received a standardized diet and water ad libitum in a 12 h 
light/darkness cycle at 22ºC. After the stabilization period, rats were randomly allocated 
into five groups: group NBc: non-burned and non-treated control rats (n=2); group Bc: 
non-treated burned control rats (n=6); group BL: the burned skin was covered with films 
containing L. plantarum, obtained with 1.6 M CaCl2,  (n=3); group BPs: the burned skin 
was contaminated with P. aeruginosa (1 x 108cfu/ml) by sterile cotton swabs (n=7); 
group BPsL: the burned skin was contaminated with P. aeruginosa and covered with 
films containing L. plantarum (n=7). To function effectively alginate dressings need to 
absorb exudate from the wound, but the burn wounds of rats are dry. Therefore films 
were hydrated with sterile phosphate buffered saline (1ml / 100mg of film) before 
application.  
All animals were subjected to the surgical procedures as follows. All rats were 
anesthetized with sodium pentobarbital (Eutasil™, 60 mg/kg, intra peritoneal; Sanofi 
Veterinária, Algés, Portugal). Depth of anesthesia was assessed by pedal reflex and 
maintenance doses were given as required. Anesthetized rats were shaved (dorsum) and 
placed onto a thermostatically controlled heating mat (Harvard Apparatus Ltd, U.K.) and 
body temperature maintained at 37±1°C by means of a rectal probe attached to a 
homeothermic blanket. A tracheotomy was performed to maintain airway patency and to 
facilitate spontaneous respiration. The thermal injury procedures were modified from 
those previously described (Walker and Mason, 1968): a 30% third degree skin burn was 
induced by immersing dorsal shaved skin in 96-99°C water for 10 seconds using a 
synthetic foam template after surgical procedure. Group NBc was submitted to identical 
procedures as the other groups except that room temperature water was used instead of 
heated water. After burn, animals were dried and placed over the heating mat. Animals 
were sacrificed 8 hours after burn injury by overdose of the anaesthetic. The experimental 
time (8 hours) was the time necessary for inhibition of P. aeruginosa in vitro (see 4.3.1). 
At the end of the experimental period, blood was collected through cardiac puncture 
and placed into a serum SST® gel and clot activator (BD Vacutainer(R) SSTTM, Becton 
Dickinson, Meylan, France). After this, lung, liver, spleen, kidney, intestine and burned 
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skin (approximately 1 cm2) samples were collected.  To determine the colony forming 
unit (cfu)/g of tissue, the specimen was homogenized in MH broth (1:10) and then 
cultured onto non-selective MH agar and selective media: Cetrimide agar for P. 
aeruginosa and MRS agar for L. plantarum. The inoculated plates were incubated at 37ºC 
and read after 24 to 48h. The blood samples and the homogenized tissues were further 
incubated at 37ºC for 24h. 100µl from the overnight cultures were plated on Cetrimide 
and on MRS agar to confirm if P. aeruginosa or L. plantarum cells less than the level of 
detection of the direct assay have passed into the blood and the organs of the animals 
(group BL, BPs and BPsL). 
Simultaneously serum aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), creatinine and urea were quantified and alterations observed were compared to 
the control groups NBc and Bc. The results were expressed as the mean ± SE and were 
compared using a one-way factorial ANOVA test, followed by a Bonferoni post-hoc-test 
using a Graph Pad Prism Statistical Package (version 4.0, USA). A p value less than 0.05 
was considered to be statistically significant on evaluating the differences between the 
groups of animals (Mitsui et al., 1999). 
 
4.3 Results 
4.3.1 Preparation and in vitro evaluation of L. plantarum loaded calcium 
alginate films 
The production of a film was observed with a minimal calcium concentration of 0.8 
M CaCl2. Below this value films did not show an adequate structure falling apart. On the 
other hand, by increasing the concentration of calcium in the calcium chloride solution, 
the time for films formation decreased together with a smaller volume observed (Table 
4.1).  
 
Table 4.1 Visual inspection of the forming films (mean and SD). 
 
CaCl2 formation solution [M] 0.8 1.6 3.2 6.4 12.8
Time for film formation [h] 3 2.5 1 1 0.25
Film major and minor axis [mm] 42.5±0.7 / 47.4±1.2 43.4±1.3 / 46.0±1.9 43.3±1.2 / 46.0±1.3 43.0±1.3 / 45.0±1.5 43.0±1.2 / 45.0±1.3
Film thickness [mm] 5.23±0.26 5.08±0.19 5.08±0.19 4.65±0.19 4.35±0.15
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The aqueous solution of CaCl2 used in a concentration up to 3.2 M did not affect L. 
plantarum viability. However, higher concentrations (6.4 M) led to both a lack of 
uniformity, i.e., L. plantarum cell concentration in the periphery of the film (2 x 
107cfu/ml) was lower compared to the cell concentration in the central part of the films (8 
x 108cfu/ml) (higher standard deviation bars) (Figure 4.1a, immobilization) and to a 
viability decrease lower than the limit of detection noted with 12.8M CaCl2 (Figure 4.1a, 
immobilization). Freeze-drying resulted in a decrease of approximately 1 log unit: from 
4.7 x 109 to 2.4 x 108cfu/ml, 3.3 x 109 to 3.0 x 108cfu/ml, 1.8 x 109 to 3.0 x 108cfu/ml of L. 
plantarum viability in films obtained with 0.8, 1.6 and 3.2M CaCl2, respectively. Stable 
viability of bacteria during six months of storage was observed in the same films (4.7 x 
109 to 5.5 x 109cfu/g; 5.9 x 109 to 1.4 x 109cfu/g; 5.9 x 109 to 2.7 x 109cfu/g) (Figure 
4.1b). 
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Figure 4.1 Viability of L. plantarum (mean and SD, n=3) in calcium alginate films obtained with 0.8M 
CaCl2 (black bar), 1.6M CaCl2 (dashed black bar), 3.2M CaCl2 (grey bar), 6.4M CaCl2 (dashed grey bar) 
and 12.8M CaCl2 (striped black bar) before and after processing (a) and throughout 6 months of storage at 
4ºC (b). 
 
a) 
b) 
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Lactobacilli loaded films were characterized by smooth surface morphology, while 
blank films by rough (Figure 4.2). 
 
  
a)     b) 
  
c)     d) 
Figure 4.2 Scanning electron photomicrographs of blank a) external and b) internal surface and L. 
plantarum loaded c) external and d) internal surface alginate films produced with 1.6M CaCl2. 
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The calcium content of films is shown in Table 4.2. It was well below from the 
amount applied in film formation in both blank and lactobacilli loaded films. The 
presence of lactobacilli led to a 1.70 up to 1.95 fold decrease of the calcium concentration 
compared to blank films. The swelling ratio of the lactobacilli loaded films (8.06 to 
10.07) was higher than the swelling ratio of blank films (3.62 to 8.96), i.e., the water 
absorption capacity increased with the decrease of calcium content. Tensile strength 
values of the lactobacilli loaded films ranged from 23 to 42 x 103 N/m2, whereas blank 
films showed smaller variations of the tensile strength values (44 to 48 x 103 N/m2). 
Similarly, Young’s modulus values in L. plantarum loaded films ranged from 8 to 23 x 
103  N/m2 and showed smaller variation in blank films (18 to 24 x 103  N/m2). Thus, the 
increase of calcium content in films was reflected by an increase in tensile strength and 
decrease of elasticity of films. The films bioadhesion values ranged from 50 to 67 x10-
2J/m2, except of 3.2M blank patch (119 x10-2 J/m2) (Table 4.2). 
 
Table 4.2 Physical characteristics of calcium alginate films (mean and SD). 
CaCl2 
formation 
solution [M]
Film calcium 
content (mM)
Thickness 
(mm)
Swelling 
ratio
Crushing 
force (N)
Tensile 
strenght
(x103 N/m2)
Young's 
modulus
(x103 N/m2)
Work of 
bioadhesion
(x10-2 J/m2) 
Peak detachment 
force
(x10-2 N/m2)
0.8 0.91 4.1±0.29 10.07±0.12 0.84±0.05 23±4 8±3 53±5 156±45
1.6 1.65 4.0±0.12 8.96±0.58 1.09±0.28 35±11 15±2 55±5 145±45
3.2 2.37 4.0±0.12 8.06±0.62 1.38±0.24 42±7 23±1 56±5 155±38
0.8 1.55 3.85±0.11 8.96±0.20 1.33±0.15 44±8 18±1 67±13 87±31
1.6 3.22 3.84±0.20 7.05±0.61 1.35±0.28 45±4 20±5 50±6 65±11
3.2 4.55 3.85±0.25 3.62±0.25 1.53±0.25 48±11 24±3 119±28 270±52
Lactobacilli 
loaded films
Blank films
 
 
The lactobacilli released in the first 10 min from 0.8 and 1.6M films corresponded to 
108cfu/g vs. 107cfu/g released from the 3.2M films. In 2 hours the released lactobacilli 
from the 3 types of films corresponded to 109cfu/g. 0.8M, 1.6M and 3.2M films released 
their total number of lactobacilli as follows: up to the forth, eight and tenth hour, 
respectively (Figure 4.3). 
The non-processed L. plantarum cultures were active against P. aeruginosa at a cell 
concentration of 1 x 107cfu/ml. After the immobilization of L. plantarum into alginate 
freeze-dried films, as well as during storage, the inhibition of P. aeruginosa was obtained 
by 6.2 x 107 ± 5.4 x 107 L. plantarum cells /ml. Inhibition of P. aeruginosa was observed 
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8h after its co-incubation with non-processed or processed to films L. plantarum (data not 
shown). 
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Figure 4.3 Release of lactobacilli from films (formed with ▲ 0.8 M; ■ 1.6M; ● 3.2M CaCl2),  
represented as log cfu/g (a) and in % (b), as a function of time. 
 
 
4.3.2 In vivo effect of L. plantarum films on P. aeruginosa 
No bacteria were isolated from the liver, spleen, kidney and lungs or from the blood 
of any rat (groups NBc to BPsL). P. aeruginosa and L. plantarum were not recovered 
from blood and organs of groups BL, BPs and BPsL. Various bacterial flora, without L. 
a) 
b) 
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plantarum and P. aeruginosa, was found in the intestines of all rats and from the skin of 
group NBc rats. 
 The burned wounds of the rats contaminated with P. aeruginosa (group BPs) showed 
microbial counts of 107-108 P. aeruginosa / g of skin. The wounds of the rats with L. 
plantarum-films (group BL) showed a bacterial load of 104 L. plantarum / g of skin. In 
group BPsL, the same number of lactobacilli per gram skin as in group BL was 
recovered. However, the number of P. aeruginosa corresponded to 102 cells per gram of 
skin, i.e. a reduction of 5 to 6 log units was observed in the presence of L. plantarum 
loaded films (Table 4.3). 
 
Table 4.3 Microbial counts (mean ± SD) in tissue obtained from burn wounds after 8h from group BL 
(treated with L. plantarum loaded films), BPs (contaminated with P. aeruginosa) and BPsL (contaminated 
with P. aeruginosa and treated with L. plantarum loaded films). 
Group L. plantarum  cfu/g skin P. aeruginosa  cfu/g skin 
BL 2.04 x 104 ± 1.75 x 104
BPs 7.36 x 107 ± 1.52 x 107
BPsL 3.63 x 104 ± 2.47 x 104 3.71 x 102 ± 2.87 x 102
 
To monitor the effect of burn and the presence of P. aeruginosa and L. plantarum in 
burn wounds on the distant organ injury in rat, several biochemical parameters were 
analysed. Blood urea and creatinine concentrations were studied to assess the renal 
function, while AST and ALT were determined to evaluate the hepatic function (Figure 
4.4). Urea and creatinine levels as well as AST and ALT were found to be significantly 
higher in burned animals (groups Bc to BPsL) than in non-burned animals (group NBc) 
(Figure 4.4, p<0.05 to p<0.001). The presence of bacteria did not affect the levels of urea 
in burned animals. Interesting to point out was the fact that lactobacilli showed a 
tendency to decrease the elevated creatinine levels induced by burn (groups BL vs Bc). 
However, when burns were contaminated with P. aeruginosa (groups BPs and BPsL) 
creatinine levels were significantly higher than in non-contaminated burned animals 
(group Bc) (p<0.05) and treatment with lactobacilli had no effect for the time of the 
experiment. The presence of P. aeruginosa and L. plantarum in group BPsL resulted in 
significantly higher AST and ALT levels compared to burned control animals (group Bc) 
(p<0.05).
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NBc Bc BL BPs           BPsL 
1P<0.05 vs NBc
2P<0.01 vs NBc
3P<0.05 vs Bc
4P<0.05 vs Bc
5P<0.05 vs BPs
 
NBc Bc BL BPs           BPsL 
1P<0.05 vs NBc
2P<0.01 vs NBc
3P<0.001 vs NBc
4P<0.05 vs Bc
 
NBc Bc BL BPs           BPsL 
1P<0.001 vs NBc
 
 
NBc Bc BL BPs           BPsL 
1P<0.05 vs NBc
2P<0.001 vs NBc
3P<0.05 vs Bc
 
Figure 4.4 Serum aspartate aminotransferase (AST), alanine aminotrasferase (ALT), blood urea and 
serum creatinine levels in non-burned (NBc) and burned (Bc) control groups and burned and exposed 
to L. plantarum loaded films (BL), P. aeruginosa (BPs) and both P. aeruginosa and L. plantarum 
loaded films (BPsL) groups. 
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4.4 Discussion 
4.4.1 Preparation and in vitro evaluation of L. plantarum loaded calcium 
alginate films 
When the cell-alginate suspension was added to CaCl2 solutions, calcium alginate 
films were formed. These gel systems evolved slowly with time because of crosslinking 
reactions, taking place during the gel formation, proceeding progressively from the 
surface to the interior (Velings and Mestdagh, 1995). The increase of calcium content 
reduced the time of film formation and allowed the building of a stronger and more 
compacted network (Table 4.1). The observed decrease in film volume could be due to 
network formation, characterised by higher complexing between the carboxylate groups 
of the guluronate monomers of alginate and the calcium cations, resulting in reduced 
space occupied by alginate and therefore decreased film volume (Velings and Mestdagh, 
1995). 
Figure 4.1 shows the viability of L. plantarum during film production and storage. 
The amount of calcium added to the film was critical to both film formation and 
lactobacilli viability. Higher the amount of calcium higher the tensile strength of the film 
but lower the number of viable bacteria. Figure 4.1a shows that immobilization with high 
concentrated calcium solutions (6.4 and 12.8M) was reflected by a decrease in the 
number of bacteria. Intracellular concentration of calcium in bacteria is tightly regulated 
ranging from 100 to 300nM (Dominguez, 2004). Calcium concentration in bacterial 
growth media can be approximately 20µM (Rosch et al., 2008). Generally, extracellular 
calcium concentration higher than 10mM is considered to be toxic to cells (Wan et al., 
2008). In the present study, the millimolar range of calcium measured in the films (Table 
4.2), when higher than 4.55mM, resulted in a decreased L. plantarum viability. The 
hypertonic calcium solutions used in the film formation could have provoked plasmolysis 
with the cytoplasm shrinking and the plasma membrane contracting from the cell wall as 
a result of internal water loss. Consequently, cells may survive and resume growth if 
favourable conditions are found, as observed during incubation in MRS broth of films 
formed with high concentrated calcium solutions (6.4 and 12.8M) (Figure 4.1a) (Korber 
et al., 1996). 
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The preservation of the films by freeze-drying has shown a decrease in L. plantarum 
viability of about 1 log unit. It must be pointed out that films formed with calcium 
concentrations up to 3.2 M have shown the smallest decrease in numbers (1 order of 
magnitude), whereas for higher calcium contents a significant decrease was observed. 
Different survival rates in films during freeze-drying might be due to the different initial 
lactobacilli concentration in films. In general, surviving fraction of the microorganisms 
increases with the increasing biomass concentration during freeze-drying, and this is 
attributed to the mutual shielding effect of the microorganisms against the severe 
conditions of the external medium (Bozoglu et al., 1987). It was observed that in the 
presence of sucrose as a protectant, 109-1010cfu/ml was an optimal initial bacterial cell 
concentration resulting in the highest survivability during freeze-drying (Costa et al., 
2000; Palmfeldt et al., 2003). On the other hand, if the number of bacteria in films is too 
low (films produced with 6.4 and especially 12.8M calcium chloride), the cell viability 
might be lowered through lack of the protective effects generated by mutual contact of 
the cells due to lack effective networks (Souzu, 2004). Furthermore, cellular damage 
induced by the hypertonic calcium solutions could have continued through the freeze-
drying procedure and in storage (Souzu, 2004). 
Once immobilization is carried out in the best conditions, films were stable overtime 
(Figure 4.1b). It means that the process of drying was adequate to preserve the bacteria 
and the calcium alginate with nutrients from the MRS broth left after incubation provided 
a proper protection to the lactobacilli. 
The morphology of the films with and without lactobacilli is quite different. Figure 
4.2 shows the surfaces of blank and loaded films. It might be due to the interaction 
between the lactobacilli cells and the calcium alginate matrix. The rough internal and 
external surfaces of films were transformed into smooth surfaces during the proliferation 
of lactobacilli in calcium alginate films. The proliferation of lactobacilli resulted in a 
decrease of the calcium content in the films, which could be due to production of lactic 
acid by the bacteria during incubation of films in MRS broth, which competes with the 
alginate for calcium (Morin et al 1992). 
Measurement of calcium content in the films has shown that a large part of calcium 
was not used in film formation (amount applied versus amount quantified). A possible 
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explanation could be that the upper layers of the films (the first to be formed) prevented 
calcium to go underneath. Velings and Mestdagh, [12] 1995 described a parabolic 
distribution in the calcium concentration in the calcium alginate gels, which is higher on 
the surface of the gel that is in contact with the formation solution than in the centre of 
the gels.  
A decrease in calcium has a destabilizing effect on the network and consequently on 
the physical properties of the films (Table 4.2). For the same surfaces (3.2 x 2.2 cm) the 
film strips have shown different thicknesses showing clearly an increase in thickness 
when lactobacilli are present. This suggests that the network is not so compact, as for the 
blanks, derived from lower calcium content, as discussed. The smaller compaction as a 
consequence increases the absorption of water by the films: the blank films show a larger 
range of swelling ratio (3.62 up to 8.96) than loaded films (8.06 up to 10.07). Results of 
the force at crush and the tensile strength emphasize the effect of the presence of 
lactobacilli. Whereas the blank strips show closer range of results (the standard deviations 
show that they were not significantly different), for the loaded strips the largest tensile 
strength almost doubles the smallest one. Still with the mechanical properties of strips, 
the Young’s modulus shows that blank strips are less elastic than the loaded ones. This 
suggests that the network formed by the calcium alginate was stronger and less elastic in 
the absence of lactobacilli. The calcium content did also affect the release of lactobacilli 
from films. Increased crosslinking density with calcium and the consequent decrease of 
porosity (Wan et al., 2008) resulted in slower release of bacteria (Figure 4.3). The 
lactobacilli were at both the surface of strips and within the network (Figure 4.2 c, d). The 
presence of surface lactobacilli explained the observed burst effect: 0.3 to 2.5% of the 
total bacterial load was released immediately after contact with PBS. 
The adhesion between the loaded film and chicken skin was reflected by the work of 
adhesion which was quite constant for loaded strips whereas for blank strips it varied 
considerably. The explanation can be formed at the surface of the strips. Figure 4.2 
clearly shows differences at the surface of strips: loaded strips have a smooth surface 
covered with bacteria whereas the blank strips have rough surface. The asperities 
observed might have increased the surface of contact between the strip and the chicken’s 
skin in a non anticipating pattern. The force at detachment showed that loaded strips 
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required generally a larger force than blank strips. However, the work of adhesion was 
smaller for loaded strips. It shows that bacteria promoted an easier detachment of films 
under tension, decreasing the adhesion work but still holding the strip, showing a higher 
force at detachment. 
 
4.4.2 In vitro and in vivo effect of L. plantarum films on P. aeruginosa 
The inhibitory effect of L. plantarum ATCC 8014 against a VIM-2-metalo-β-
lactamase producing P. aeruginosa FFUL 1396 was investigated both in vitro and in vivo. 
In vitro results have shown that L. plantarum cultures at high cell concentrations of 107-
108cfu/ml before and after immobilization into calcium alginate films were effective 
against the multi-resistant P. aeruginosa. Microbial counts of P. aeruginosa in skin have 
shown that lactobacilli have caused a pronounced decrease (5 to 6 log units) of P. 
aeruginosa after 8h in a burn model of rat. These results confirmed an earlier report of 
the inhibition of a standard clinical isolate of P. aeruginosa PA100 by L. plantarum 
ATCC 10241 (Valdez et al., 2005) and furthermore showed that alginate films could be a 
suitable matrix preserving both viability and antibacterial activity of lactobacilli. In the 
present study a model of burn injury in rat was used, whereby a group of non-burned rats 
was compared to burned and contaminated burned rats. The observed increases of 
transaminases (AST and ALT) levels induced by burn were further elevated by the 
contamination of the burns with bacteria (group BPsL), suggesting distant organ injury of 
liver tissues. 
Bacterial translocation from the burn wounds was not observed since no bacteria were 
recovered from the blood, liver, spleen, kidneys and lungs. This observation confirms the 
results of Peral et al., 2009, indicating that 48h after the end of the treatment of burned 
patients with L. plantarum cultures, this bacterium was not recovered from either 
peripheral blood or wound samples. This is a promising outcome because in situations 
where lactobacilli are to be used, the effect occurs at the burned location only. 
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4.5 Conclusions  
The study confirmed the inhibitory activity of immobilized lactobacilli in a calcium 
alginate films at a concentration of 108cfu/ml in a model of burn injury in the rat. 
Films could be considered solid dosage forms which are easier to handle and deliver 
to patients than the starting cell cultures or other liquid dosage forms. Thus, the 
developed L. plantarum loaded films might contribute to the use of lactobacilli as an 
alternative in topic burn wound prophylaxis and treatment. 
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CHAPTER 5 
 
CONCLUDING REMARKS 
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The present work has confirmed the possibility of using solid dosage forms (tablets, 
pellets, beads and films) to deliver viable and antibacterially active lactobacilli, as proven 
by in vitro and in vivo tests. 
The factors affecting the viability of the bacteria throughout the manufacture of solid 
dosage forms were: probiotic strain, formulation into which bacteria were inoculated, 
pressure applied in processing and process of drying. 
As anticipated the spores (Bacillus subtilis) were more resistant than vegetative forms 
(Lactobacillus plantarum, Lactobacillus rhamnosus strain GG, Lactobacillus lactis and 
Lactobacillus bulgaricus, by decreasing order of viability) to processing. 
The stabilization of the bacteria has shown that protective matrix (e.g. skim milk) and 
cryoprotectors (e.g. glycerol) must be present at early stages of bacterial de-hydration by 
freeze-drying (FD). The choice of excipients is critical for bacterial survival. For instance 
the presence of skim milk and inulin preserved the viability of bacteria, whereas, 
microcrystalline cellulose, a common excipient for solid dosage forms, have shown a 
deleterious effect on bacterial viability. 
Pressure, whether applied during extrusion or compaction reduced bacterial viable 
counts, although a relationship between the pressure applied and the decrease on viability 
was not clear. Further, pressure applied to dry bacteria (tabletting of freeze dried bacteria 
by direct compression) was preferable to pressure applied to powder mixtures containing 
fresh bacterial suspensions (extrusion and spheronisation).  This emphasizes that freeze-
drying was less deleterious to bacteria than air drying. The application of a coat to dried 
bacteria (pellets and tablets) did not modify their viability. 
Contrary to extrusion and compaction, the mild conditions during immobilization of 
bacteria into alginate beads and films preserved high bacterial viability. Alginate matrix 
was also suitable for preservation of lactobacilli antibacterial activity. 
Finally, the high numbers of viable and antibacterially active lactobacilli present at 
the end of processing and storage of different dosage forms anticipate the successful use 
of these systems in clinical applications, concretely in burn wounds. 
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